{"title": "PDF", "author": "PDF", "url": "https://biomedizin.unibas.ch/fileadmin/user_upload/biomedizin/about_us/media/dbm_facts/DBM_Facts_15_2.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "2 15Stem Cells and Hematopoiesis | Hei senn eich dahaam \n| Grosse Ferien!Periodisches Informationsblatt des Departementes Biomedizin\nUniversit\u00e4t Basel, Universit\u00e4tsspital Basel undUniversit\u00e4ts-Kinderspital beider BaselDBM Facts 2|2015  Departement BiomedizinRedaktion\nHeidi Hoyermann\n\u00dcbersetzungen\nPaula Cullen , Th\u00e9r\u00e8se Resink\nLayout\nEric Spaety, Morf Bimo Print AG, Binningen\nIT-Unterst\u00fctzung\nNiklaus Vogt\nAdministration\nManuela Bernasconi\nFotos\nFrank Neumann (Seite 28),Bernd Schwendele (Seiten 2 und  9)Titelfoto: shutterstock\nDruck\nMorf Bimo Print AG, Binningen\nAnschrift\nRedaktion DBM FactsDepartement BiomedizinHebelstrasse 204031 Baselheidi.hoyermann@usb.chIMPRESSUMEditorial\n    1\nAuszeichnungen/Congratulations 7\nBiosafety vs BBQ 10\nArt  27\nMitarbeitende/Colleagues \n 28\nSeason: Entering the ice cream business 42\nDas DBM stellt sich vor 43\nHei senn eich dahaam\nvon Katharina Leonards und\nFlorian MarquardsenStem Cells and Hematopoiesisfrom Claudia Lengerke\nMalen mit Lichtvon Ronny NienholdFarewell lecture of  \nAlbert Urwyler\nGrosse Ferien!\n2\n31\n34\n 38\n9DBM Facts 2|2015  Department of BiomedicineEDITORIAL\nRadek Skoda\nLeiter DBM\nLiebe Leserinnen und Leser \nIm August wird das DBM feierlich sein 15j\u00e4hriges Jubil\u00e4um mit einem internationalen Symposium \nund anschliessendem Fest begehen (Seite 8). \nWir freuen uns, Sven Cichon als Vertreter der Medizinischen Querschnittfunktionen in der DBM-Lei -\ntung begr\u00fcssen zu d\u00fcrfen. Er tritt die Nachfolge von Albert Urwyler an, der per Juni 2015 aus dem \nGremium ausscheidet.  Wir danken Albi Urwyler f\u00fcr seine vielen Beitr\u00e4ge und grosse Unterst\u00fctzung \ndes DBM sowohl in der DBM-Leitung als auch w\u00e4hrend seiner Zeit als Dekan der Medizinischen Fa -\nkult\u00e4t. Wir freuen uns, dass er wissenschaftlich am DBM noch weiter t\u00e4tig sein wird (Seite 9)!\nIn der vorliegenden Ausgabe erfahren Sie mehr \u00fcber die Aktivit\u00e4ten der Forschungsgruppe \u201cStem \nCells and Hematopoiesis\u201d von Claudia Lengerke (ab Seite 2). Wir pr\u00e4sentieren Ihnen die neuesten \nPublikationen (ab Seite 12), Roy Allenspach stellt sich die f\u00fcr den Monat Juni berechtigte Frage Biosafety oder BBQ (ab Seite 10), wir sehen die Welt mit den Augen eines Fotographen (ab Seite 32) \nund lernen die \u00e4lteste deutsche Stadt kennen (ab Seite 34). Neue Jobs f\u00fcr Forschungsgruppenlei -\nter finden Sie auf Seite 42.\nEine spannende Lekt\u00fcre und sch\u00f6ne Ferien (vielleicht auch einmal anders \u2013 siehe Seite 38)!\nDear Readers\nIn August we will celebrate 15 years of the DBM with an international symposium followed by celebra -\ntory festivities (page 8).\nWe are delighted to welcome Sven Cichon as representative of the \u201cMedizinische Querschnittfunktio -\nnen\u201d  to the DBM executive committee. He joins as successor to Albert Urwyler who retired from the \ncommittee in June 2015. Sincerest thanks to Albi Urwyler for his many contributions to, and his great \nsupport of, the DBM, as well as the DBM executive committee, and also for the time he spent as the Dean of the Medical Faculty. We are delighted that he will continue to remain scientifically active at the \nDBM (page 9)!\nIn this issue you can find out more about the activities of Claudia Lengerke\u2019s \u201cStem Cells and Hemat -\nopoiesis\u201d research group (from page 2). We present the latest publications (from page 12); Roy \nAllenspach asks a rather apt question for June: biosafety or barbecue? (from page 10); we see the \nworld through the eyes of a photographer (from page 32); and get to know the oldest German city \n(from page 34). New positions for research group leaders can be found on page 42.\nEnjoy reading and wishing you all happy holidays (perhaps even something different \u2013 see page 38)!DBM Facts 2|2015  Departement Biomedizin2 WISSENSCHAFT | SCIENCE  DBM HEBELSTRASSE\nOur research group relocated from T\u00fcbingen (Ger -\nmany) to Basel in August 2013. Since then several new \nteam members have joined. We enjoy the international atmosphere of our lab and the institute, and the close exchange with the neighbouring research groups. Our research focuses on stem cell mechanisms in regen -\neration and disease. We hypothesize that stemness pathways contribute to cancer initiation, therapy resis -\ntance and relapse. By analysing stem cell specific fea -\ntures and looking at cancer and cancer therapies from a stem cell perspective, we aim to develop alternative \ntreatment approaches. We are especially interested in \nleukemia and in the oncogenic roles of transcriptional factors regulating stem cells during development (EVI1, CDX2, SOX2). Additional to conventional work with mu -\nrine and human cells, we use the zebrafish model to \ninvestigate these questions. In the following sections \nindividual projects of our research group members are \noutlined. Stem Cells and Hematopoiesis\nThe blood group:\nElisa Alghisi & Martina Konantz (Postdocs)Martina\u2019s and Elisa\u2019s projects focus on the elucidation \nof the cellular and molecular mechanisms controlling hematopoietic stem cells (HSCs) in embryonic devel -\nopment. The projects take advantage of the zebrafish as a new tool to study blood cell development and dif -\nferentiation. The zebrafish (Danio rerio)  is a small fresh -\nwater teleost fish that has a short generation time and \nprovides large numbers of offspring. During the last de -\ncade, the zebrafish has emerged as a powerful model \norganism for developmental biology studies and is also increasingly used in translational research. In spite of anatomical dissimilarities, major blood cell types and genetic pathways controlling hematopoiesis appear evolutionary conserved between fish and mammals and discoveries made from zebrafish blood screens have \nThe Stem cells and Hematopoi -\nesis group (from left to right):\nAnna Lenard, Martina \nKonantz, Melanie Neutzner, \nThorsten Sch\u00e4fer, Matyas Ecsedi, Tamara Pereboom (back); Elisa Alghisi, Jo\u00eblle\nM\u00fcller, Anna Paczulla, Hui \nWang, Claudia Lengerke (front).\nDBM Facts 2|2015  Department of BiomedicineDBM HEBELSTRASSE  WISSENSCHAFT | SCIENCE  3\nbeen already successfully translated to clinical trials in \nhumans (North et al.; 2007; Goessling et al., 2011). Be -\nsides its amenability for screens, major advantages of the zebrafish model are its optical transparency and the extra-uterine development allowing in vivo  observation \nof developmental processes such as the birth of HSCs from endothelial cells in the aorta-gonado-mesoneph -\nros region of the dorsal aorta (Figure 1). \nIntriguing questions emerging from these studies that \nare followed up by our research group include (1) which \nendothelial cells are capable of transitioning to hema -\ntopoietic stem cells and (2) which molecular cues are involved in this process. Regarding the latter, previ -\nous reports identify a major role of the NOTCH path -\nway in hematopoietic stem cell emergence, and VEGF and SHH signalling as involved upstream regulators of NOTCH. Martina\u2019s on-going research project points out the ecotropic viral integration site 1 (EVI1)  gene as an in -\ndependent novel player inducing hematopoietic fate in endothelial cells by fine-tuning NOTCH levels. Currently, the molecular mechanisms involved in this process are investigated in more detail, for example by Elisa\u2019s proj -ect analysing potential contributions of the trichorhino -\nphalangeal syndrome 1 (trps1)  gene \u2013 a GATA family tran -\nscriptional factor \u2013 to evi1-induced hematopoiesis. \nWhile EVI1 has not yet been reported to play a role in \nearly HSC specification, previous reports indicate impor -\ntant roles of EVI1 in adult hematopoietic and leukemic \nstem cell biology. Indeed, the EVI1 gene has originally \nbeen identified as a retroviral insertion site in myeloid tumors in AKXD mice and since then, emerged as one of the most potent oncogenes and molecular predictors of adverse outcome in myeloid leukemia (Mucenski et al., \n1988). Recently, we could show that EVI1 also regulates \nlymphatic blood cells, enhancing for example apopto -\nsis resistance and in vivo  leukemogenicity in acute lym -\nphoblastic leukemia cells and influencing the biology of \nchronic lymphatic leukemia cells (Konantz et al., 2013, Vasyutina et al., 2015). To further investigate the role of EVI1 in leukemia, Elisa is currently generating zebrafish \nmodels for EVI1-overexpression. Specifically, she takes advantage of the established Gal4-UAS transgenic sys -\ntem to induce the overexpression of the zebrafish evi1 \nhomologue into defined zebrafish blood cell types us -\ning specific hematopoietic promoters. Ideally, these transgenic models will provide a platform for compar -\ning the transforming potential of evi1 overexpression \non immature versus specialized blood cells, and even -\ntually may inform on the cell of origin of evi1 overex -\npressing leukemias. Prospectively, this system shall be used to explore functionally potential cooperating ge -\nnetic events observed in EVI1 overexpressing human \nleukemia, such as the recently reported RAS pathway mutations. Moreover, the model can potentially be em -\nployed for drug screens with the aim of identifying new molecular pathways involved in evi1-induced malignant \ntransformation and molecules specifically targeting these pathways or evi1 itself. \nAnna Lenard (Postdoc)Novel therapies that emerge from screens need to first \nundergo safety assessment before they move on to the first clinical trials. Hematologic findings are one of the most common side effects encountered in this pre-clin -\nical safety testing. The consequences of direct or indi -\nFigure 1: In the zebrafish embryo, HSC also emerge from the\nventral wall of the dorsal aorta of the AGM region. By using a double transgenic line (Tg(cmyb:GFP;kdrl:mKate-CAAX)), we are \nable to monitor the in vivo formation and emergence of these \ncells (white arrows). DBM Facts 2|2015  Departement Biomedizin4 WISSENSCHAFT | SCIENCE  DBM HEBELSTRASSE\nrect damage to blood cells and their precursors can be \npotentially life threatening, and hence, hematotoxicity can lead to the termination of a promising drug candi -\ndate. Current hematotoxicity testing employs in vitro \nmodels with a cell viability read-out. However, this ap -\nproach only allows a limited read-out and, for example, does not capture effects on later maturation stages of blood cell progenitors. As part of the Roche postdoc -\ntoral fellowship program, Anna uses her zebrafish and live imaging experience to establish a zebrafish-based hematologic toxicity assessment model together with the Roche Preclinical Safety Department.\nUsing flow cytometry and high-content in vivo  imag -\ning of fluorescent reporter expression, she analyzes \nthe effects of drug exposure on defined hematopoietic lineages with regard to cell numbers, distribution and activity. She is currently establishing various transgenic zebrafish lines labeling different types and stages of blood cells. Double transgenic combinations thereby al -\nlow analysis of different cell types in one embryo, for example progenitors and mature cells of the same or unrelated lineages (Figure 2).Anna Paczulla (PhD student)\nAnna\u2019s project focuses on the role of the caudal-type \nhomeobox (CDX)  gene family member CDX2  in acute my -\neloid leukemia (AML). CDX genes were shown to regulate \nembryonic hematopoiesis via downstream HOX genes \nand interactions with the WNT  signaling pathway. While \nno longer expressed in adult hematopoietic stem and progenitor cells, CDX2  is aberrantly up-regulated via yet \nunknown mechanisms in the majority of acute myeloid leukemias. Anna explores the molecular regulation and functional relevance of CDX2  expression in human AML \nand its importance for leukemia induction in healthy hematopoietic cells. Some of her recent findings point out interesting and unsuspected roles of CDX2  on leuke -\nmic cell adhesion via non-cell autonomous interactions with the bone marrow niche (Figure 3). Anna currently explores the molecular mechanisms underlying these effects, which apparently involve the WNT signaling pathway. She further studies the interaction of human AML cells with the bone marrow niche using different experimental conditions and murine xenograft trans -\nplantation models.\nUsing zebrafish as xenograft models for human\ncancer cells:\nJo\u00eblle M\u00fcller (Master student) Jo\u00eblle, a master student in the lab, explores, together \nwith Martina, the zebrafish as a xenograft model. Hu -\nman cancer cells have been show to grow upon xeno -\ntransplantation in zebrafish embryo or adult fish. Em -\nbryo xenotransplantations especially provide important advantages when compared to conventional murine models, since they allow early assessment of in vivo \ntumorigenicity within few days as well as in vivo  visu -\nalization of tumor-induced angiogenesiss and invasive -\nness (Konantz et al., 2013). Potential draw-backs are the environmental differences in niches and growth factors as well as temperature (29\u00b0C for zebrafish, 35\u00b0C for xenotransplanted zebrafish) between zebrafish and humans. Currently, Martina and Jo\u00eblle have successfully transplanted several solid tumor cells including primary \nFigure 2: Various transgenic lines that fluorescently label blood \ncells and can be used to monitor the effects of drug treatment both microscopically and after dissociation into single cells via \nflow cytometry.DBM Facts 2|2015  Department of BiomedicineDBM HEBELSTRASSE  WISSENSCHAFT | SCIENCE  5\nmaterial and leukemic cell lines and explored tumor \ninduction using different methods (microscopy, qRT-PCR, FACS and/or histopathology, see figure 4). Next to optimizing the experimental transplant conditions and readout, they investigate whether engraftment in fish correlates with disease characteristics and can be mod -\nulated by treatments with small molecules added to the water or specific genetic manipulations. Furthermore, \nFigure 3: Adhesion assays using MS5 stromal \ncells reveal lower adhesion capacity of CDX2 knockdown GFP positive cells as compared \nto control transduced GFP-positive SKM1 \ncells. Experimental procedure: SKM1 cells were transduced with GFP-control or CDX2 shRNA GFP-lentiviruses to obtain control and respectively knockdown cells. Effectively transduced cells were selected by FACS and \nplated on a MS5 bone marrow stroma cell \nmonolayer. After 90 minutes of co-culture the supernatent was removed and the cells that remained attached were trypsinized \ntogether with MS5 cells and analyzed via \nmicroscopy (A) and flow cytometry  (B) for GFP positive cells.\nFigure 4: Human acute myeloid leukemia \ncells form tumors upon xenotransplanta -\ntion into zebrafish embryo. Experimental \nProcedure: (A) Human cancer cells are either genetically or transiently labeled via dif -\nferent cell tracker for long term tracing of \nliving cells (CM-DiL, Vybrant\u00ae DiO, Molecular \nprobes\u00ae, Invitrogen). Cells are then trans -\nplanted into the yolk of 48 hpf old zebrafish embryos. After 1 hour of recovery at 29\u00b0C, \nfish are screened for positive fluorescence at \nthe injection site. Fish are then transferred to 35\u00b0C and incubated for the next 3-5 days. (B) Growth of human cancer cells can then be monitored via histopathological stainings \n(H&E staining) or fluorescence microscopy, \nflow cytometry and qRT-PCR (not shown).DBM Facts 2|2015  Departement Biomedizin6 WISSENSCHAFT | SCIENCE  DBM HEBELSTRASSE\nthe relationship between tumor cells and host cells such \nas macrophages in investigated in this model. Our re -\nsearch group also used this model in collaborations with other researchers (Viola Heinzelmann, Francis Jacob at the DBM and Sven Perner, University of Bonn). \nThe breast cancer team:\nHui Wang (PhD student), Thorsten Sch\u00e4fer\n(Postdoc) & Tamara Pereboom (Technician)\nProjects started in the research consortia at our previous \nfacility in T\u00fcbingen involved research on cancer stem cells in other tumor models such as breast carcinoma (BC). BC is the most common type of malignant disease and one of the leading causes of cancer death in women worldwide. In spite of recent progresses in therapy, BC patients carry a life-long risk of disease recurrence. BC relapse is thought to originate from clonogenic breast carcinoma stem cells that metastasize, survive anti-tumor therapies and eventually re-initiate disease. Un -\nderstanding the molecular mechanisms defining breast carcinoma stem cells may lead to the discovery of mol -\necules effectively targeting this population. \nEVI1 gene activation has also been observed in solid \ncancers including breast carcinoma. In her research \nproject, Hui investigates in detail the expression, func -\ntional roles and molecular partners of EVI1 in breast car -cinoma. By performing EVI1 knockdown experiments \nusing lentiviral particles, she found that EVI1 promotes \ncell proliferation and apoptosis resistance. Interestingly, estrogen exposure can rescue  EVI1 -mediated growth in -\nhibition suggesting that the two factors act on a com -\nmon downstream pathway. Moreover these data imply that EVI1 expression is especially relevant for the growth \nof estrogen receptor negative breast carcinomas, which could be indeed confirmed analysing survival data in a larger cohort of breast carcinoma patients in collabora -\ntion with Sven Perner\u2019 group in Bonn and the University \nHospital Z\u00fcrich (Z. Varga & H. Moch). Next to further \nelucidation of the molecular mechanisms of EVI1-driven \ncell growth, Hui\u2019s future areas of investigation include the role of EVI1 in bone marrow metastasis of human \nbreast carcinoma cells. \n \nNext to his recent interest in exploring biochemical as -\npects of EVI1 regulation in collaboration with the blood \ngroup and Hui, Thorsten investigates, together with Hui \nand Tamara, the regulation of the transcriptional master regulator SOX2 (sex determining region Y - Box 2)  in breast \ncarcinoma stem cells. SOX2 is a key regulator of pluripo -\ntency in embryonic stem cells and plays important roles in early organogenesis. More recently, SOX2  expression \nwas documented in various cancers and suggested as a breast carcinoma stem cell marker (Bareiss et al., 2013). Thorsten and Hui used a reporter assay with a stem cell-specific regulatory SOX2  enhancer and identified the \nkinase AKT as an upstream regulator of SOX2 expres -\nFigure 5: AKT kinase determines breast car -\ncinoma cell clonogenicity via regulation of \nSOX2 subcellular localization and protein \nturnover. DBM Facts 2|2015  Department of BiomedicineDBM HEBELSTRASSE  WISSENSCHAFT | SCIENCE  7\nsion in breast carcinoma stem cells. SOX2 and pAKT are \nco-expressed in putative breast carcinoma stem cells, and depletion of either of the two reduces breast carci -\nnoma clonogenicity. Mechanistically, Thorsten showed that AKT physically interacts with SOX2 to modulate its subcellular distribution and thereby modulating protein stability (Figure 5). These data indicate promising appli -\ncations for AKT-inhibitors in the treatment of SOX2-pos -\nitive breast carcinoma patients. \nSelected References\nMucenski, M. L. et al. Identification of a common ecotropic \nviral integration site, Evi-1, in the DNA of AKXD murine\nmyeloid tumors. Mol Cell Biol 8, 301-308 (1988).\nNorth TE, Goessling W, Walkley CR, Lengerke C, Kopani \nKR, Lord AM, et al. Prostaglandin E2 regulates vertebrate \nhaematopoietic stem cell homeostasis. Nature. 2007 Jun;447(7147):1007-11.\nGoessling W, Allen RS, Guan X, Jin P, Uchida N, Dovey M, et \nal. Prostaglandin E2 enhances human cord blood stem cell \nxenotransplants and shows long-term safety in preclinical \nnonhuman primate transplant models.Cell Stem Cell. 2011 Apr;8(4):445-58.Tamara Pereboom and Melanie Neutzner\nNext to providing experimental support for different \nprojects in the lab, Tamara is managing our primary cells database and, together with Melanie, organizes admin -\nistratively our research laboratory.\nClaudia Lengerke\nKonantz, M. et al. EVI-1 modulates leukemogenic potential \nand apoptosis sensitivity in human acute lymphoblastic leu-\nkemia. Leukemia 27, 56-65, doi:10.1038/leu.2012.211 (2013).\nVasyutina, E. et al. The regulatory interaction of EVI1 with the \nTCL1A oncogene impacts cell survival and clinical outcome \nin CLL. Leukemia, doi:10.1038/leu.2015.114 (2015).\nKonantz, M. et al. Zebrafish xenografts as a tool for in vivo \nstudies on human cancer. Annals of the New York Academy of Sciences 1266, 124-137, doi:10.1111/j.1749-6632.2012.06575.x \n(2012).\nBareiss, P. M. et al. SOX2 expression associates with stem cell \nstate in human ovarian carcinoma. Cancer research 73, 5544-\n5555, doi:10.1158/0008-5472.CAN-12-4177 (2013).\nDissertationen  \nAm  5. M\u00e4rz 2015 konnte Erez Dror   von der For -\nschungsgruppe Diabetes Research (Departement Bi -\nomedizin Hebelstrasse) seine Dissertation mit Erfolg beenden. Er widmete sich in seiner Doktorarbeit dem \nThema \u201cPhysiological synergy between IL-1 \u03b2 and insu -\nlin on glucose disposal and macrophage activity\u201d.\nAuszeichnungen  \nVenia docendi verliehen\nIn ihrer Sitzung am 15. April 2015 hat die Regenz der Universit\u00e4t Basel Aim\u00e9e Zuniga  von der Forschungs -\ngruppe Developmental Genetics (Departement Biome -\ndizin Mattenstrasse) die Venia docendi f\u00fcr Experimen -\ntelle Medizin verliehen. In ihrer Sitzung vom 20. Mai 2015 hat die Regenz Adrian Egli  von der Forschungs -\ngruppe Applied Microbiology Research (Departement Biomedizin Hebelstrasse) und Giandomenica Iezzi von der Forschungsgruppe Cancer Immunotherapy  (Departement Biomedizin Hebelstrasse) ebenfalls je -\nweils die Venia docendi f\u00fcr Experimentelle Medizin verliehen, Min Jeong Kim  von der Forschungsgruppe \nMolecular Nephrology (Departement Biomedizin He -\nbelstrasse)  erhielt die Venia docendi f\u00fcr Nephrologie. Sie sind damit befugt, den Titel eines Privatdozenten zu f\u00fchren.\nDas DBM gratuliert ganz herzlich!8 WISSENSCHAFT | SCIENCE  DBM\nDBM Facts 2|2015  Departement Biomedizin\n15 years Department of Biomedicine \n \nAnniversary Symposium \n \nAugust 21, 2015  \n8:00 \u2013 17:30 \nGrosser H\u00f6rsaal, ZLF \n \nElaine Fuchs, Rockefeller University \nMarkus Heim, DBM \nCatherine Lubetzki, Inserm Paris \nIvan Martin, DBM \nErich Nigg, Biozentrum \nStuart Orkin, Harvard Medical School \nEd Palmer, DBM \nRenato Paro, D-BSSE \nErika Pearce, Washington University \nTania Rinaldi, DBM \n \nKeynote Lecture \nGeoffrey West, Santa Fe Institute DBM Facts 2|2015  Department of BiomedicineDBM  WISSENSCHAFT | SCIENCE  9\nWith his farewell lecture\n\u201cAn\u00e4sthesie 2030 \u2013 mehr, schneller, besser?\u201d (Anaesthesia 2030 \u2013 more, faster, better?) on May 21st 2015 Albert Urwyler formally said cheerio to the USB. While the Department of \nAnaesthesia has to face the future \nwithout one of their best \u2013 if not the very best \u2013 clinicians, the DBM can continue to count on Albi. Havingconcluded his many other long-standing functions as Dean, Chief Physician, Deputy Head of theDepartment of Anaesthesia and mem-ber of the DBM governing body, Albi will now further pursue and reinforce his research activities in the labora-\ntory of Perioperative Patient Safety.\nAlbi, we will be delighted to see you more often in the DBM.Farewell lecture of Albert UrwylerDBM Facts 2|2015  Departement Biomedizin10 DBM CORE FACILITIES  DBM\nBiosafety vs BBQ\nWie konnte es nur so weit kommen? Es ist Wochenende, \nmeine Familie ist weg und ich h\u00e4tte ein bisschen Zeit f\u00fcr mich. Ich k\u00f6nnte mir auf BBC ein Rugby Spiel anschauen, ich k\u00f6nnte einfach in den Garten sitzen und die Sonne geniessen oder ein gutes Buch lesen. Ich k\u00f6nnte mich mit Freunden in der Stadt treffen. Aber nein, ich sitze zuhause vor dem Computer und mache mir Gedanken zu einem Artikel, den ich f\u00fcr die DBM Facts schreiben soll. Das Einzige, das es einigermassen ertr\u00e4glich macht, hab ich vor etwa zwei Stunden auf den Grill gelegt.\nDas Erste, was ich mich fragte, war: Was kann ich zum \nThema Biosicherheit schreiben? Dann musste ich mit einem Schmunzeln an die zwei meist geh\u00f6rten S\u00e4tze denken, die ich am DBM bis jetzt geh\u00f6rt habe. Wann im -\nmer ich jemanden, der ohne gr\u00fcnen Kittel in einem BSL2 Labor arbeitete, darauf ansprach, bekam ich als Antwort zu h\u00f6ren: \u00abSorry. You are right\u00bb oder \u00abIch hab das Zell -\nkulturlabor erst gerade betreten.\u00bb Egal, ob jemand seine Zellen durch das Mikroskop betrachtete oder an der bi -\nosafetybench sass und seine Zellen teilte. Gebetsm\u00fch -\nlenartig und mit grosser \u00dcberzeugung: \u00abIch habe das Zellkulturlabor erst gerade betreten.\u00bb Was mich aber immer wieder erstaunte: Ich habe noch nie jemanden beim Arbeiten in einem BSL2 Labors ohne Handschuhe gesehen. Ein Schelm, wer da was B\u00f6ses denkt.\nAuf keinen Fall m\u00f6chte ich hier jemanden an den Pran -\nger stellen oder Euch ein schlechtes Gewissen einreden. \nUnd ich denke, man hat sogar bis zu einem gewissen Punkt Verst\u00e4ndnis, wenn es gef\u00fchlte 30\u00b0C in einem BSL2 Labor hat. Aber nichts desto trotz gibt es die Biosi -\ncherheitsrichtlinien aus einem guten Grund. Sie existie -\nren nicht, um Euch das Leben schwer und kompliziert zu machen. Viel mehr sollt Ihr und die Umwelt vor den Organismen, mit denen Ihr in den BSL2 Labors arbeitet, gesch\u00fctzt werden. Durch die Massnahmen, die wir am DBM haben, soll letztlich eine Sicherheitskultur entste -\nhen, bei der die Regeln ganz normal in den Laboralltag \u00fcbergehen. Wie ich aber k\u00fcrzlich an einem Kurs zum Thema Arbeits -\nsicherheit gelernt habe, wird es trotz allen Regeln und Richtlinien, Eurer Professionalit\u00e4t und Vorsicht fr\u00fcher oder sp\u00e4ter zu einem Unfall in einem BSL2 Labor kom -\nmen. Nach SUVA (Schweizerische Unfallversicherungs -\nanstalt) ist es einfach eine Frage der Wahrscheinlichkeit. Je \u00f6fter etwas gemacht wird, desto gr\u00f6sser wird die Wahrscheinlichkeit, dass etwas schief l\u00e4uft. Dass es zu einem Unfall kommt, k\u00f6nnen wir leider nicht verhin -\ndern. Aber wir k\u00f6nnen mit unserem t\u00e4glichen Verhalten sehr wohl die Wahrscheinlichkeit verringern. Und dies \nist mit sehr geringem Aufwand und ein bisschen Diszi -\nplin m\u00f6glich. Setzt einfach die Regeln, die wir am DBM \nbetreffend Biosicherheit haben, so pragmatisch wie m\u00f6glich in Eurem Arbeitsalltag um und alles wird gut.\nIn diesem Sinn auf zu meinem Grill:\nSpare Ribs mit einer sticky sauceDie Silberhaut von der Knochenseite der Ribs ent -\nfernen und das Fett trimmen. Jeden Knochen auf \nder Unterseite leicht einschneiden. Die Zutaten f\u00fcr den Dry Rub gut vermischen, die Spare Ribs mit dem Dry Rub bestreuen und in Frischhaltefolie ein -\nwickeln. \u00dcber Nacht im K\u00fchlschrank marinieren. \nF\u00fcr den Rub braucht Ihr: 3EL grobes Meersalz, 3EL \nsmoked Paprika (im Globus erh\u00e4ltlich), 2EL brauner \nRohrzucker, 2TL Zwiebelpulver, 1TL Knoblauchpulver, \n1TL Piment, 1TL frisch gemahlener schwarzer Pfeffer, \u00bc TL frisch geriebener Muskat und \u00bd TL Zimtpulver. \nDie Zutaten f\u00fcr den Finishing Glaze in einen Kochtopf \ngeben, gut umr\u00fchren, kurz aufkochen lassen und 20 Minuten k\u00f6cheln lassen, hierbei immer wieder umr\u00fch -\nren.DBM Facts 2|2015  Department of BiomedicineDBM  DBM CORE FACILITIES  11\nF\u00fcr den Glaze braucht Ihr: 1 Tasse Tomatenketchup, \n\u00bc Tasse brauner Rohrzucker, \u00bc Tasse Honig, 1EL Apfe -\nlessig, 1EL grobk\u00f6rniger Senf, 1EL Zitronensaft, Abrieb einer Zitrone, 1EL Worcestershiresauce, 1TL Zwiebelpul -\nver, \u00bdTL Knoblauchpulver, \u00bdTL Meersalz, \u00bdTL frisch ge -\nmahlener schwarzer Pfeffer und \u00bc TL Cayennepfeffer.Die Ribs verbringen mindestens 4 Stunden im Grill (geht auch im Backofen). Die Temperatur sollte die gesamte Garzeit zwischen 110\u00b0 und 130\u00b0 Celsius gehalten wer -\nden.\nDie Spare Ribs auswickeln und mit der Fleischseite nach \nunten (indirekte Hitze) in den Grill legen. Nach 45 Mi -\nnuten die Ribs wenden und weitere 45 Minuten im Grill \nlassen.\nDie Spare Ribs vom Grill nehmen und die einzelnen \nRacks in Alufolie wickeln. Pro Rack 2\u20133 EL Apfelsaft oder Ananassaft mit in die Folie geben. Nun die Spare Ribs in der Alufolie f\u00fcr weitere 1,5 Stunden in den Grill legen.Die Spare Ribs aus der Alufolie nehmen und d\u00fcnn mit dem warmen Finishing Glaze bepinseln, mindestens weitere 60 Minuten grillen und darauf achten, dass sie nicht zu dunkel werden. Ab und zu erneut mit dem Fi -\nnishing Glaze bepinseln.\nDie Ribs im sogenannten \u00abCadillac Cut\u00bb servieren \u2013 ein \nKnochen mit jeweils Fleisch rechts und links davon.\nRoy Allenspach12\t PUBLICATIONS \t DEPARTEMENT \tBIOMEDIZIN\nDBM \tFacts \t2|2015 \t Departement \tBiomedizinDuring \tinfection, \tthe\trelease \tof\tdamage-associated \tmolecular \tpatterns,\t\nso-called \t\u201calarmins,\u201d \torchestrates \tthe\timmune \tresponse. \tThe\talarmin \tIL-\n33\tplays \ta\trole\tin\ta\twide \trange \tof\tpathologies. \tUpon \trelease, \tIL-33 \tsignals\t\nthrough \tits\treceptor \tST2,\twhich \treportedly \tis\texpressed \tonly\ton\tCD4+\tT\t\ncells \tof\tthe\tTh2\tand\tregulatory \tsubsets. \tHere \twe\tshow \tthat\tTh1\teffec -\ntor\tcells \talso\texpress \tST2\tupon \tdifferentiation \tin\tvitro \tand\tin\tvivo\tduring\t\nlymphocytic \tchoriomeningitis \tvirus \t(LCMV) \tinfection. \tThe\texpression \tof\t\nST2\ton\tTh1\tcells \twas\ttransient, \tin\tcontrast \tto\tconstitutive \tST2\texpression\t\non\tTh2\tcells, \tand\tmarked \thighly \tactivated \teffector \tcells. \tST2\texpression\t\non\tvirus-specific \tTh1\tcells \tdepended \ton\tthe\tTh1-associated \ttranscrip -PNAS\b cgi/doi/10.1073/pnas.1418549112\b \b IF\b9.809\nT-bet\u2013\t and\tSTAT4\u2013dependent\t IL-33\t receptor\t expression\t directly\t promotes\t\nantiviral\t Th1\tcell\tresponses\t\nClaudia \bBaumanna,b,1,\bWeldy \bV.\bBonillac,1,\bAnja \bFr\u00f6hlicha,b,\bCaroline \bHelmstettera,b,\bMichael \bPeinea,b,\bAhmed \bN.\bHegazyd,\nDaniel \bD.\bPinschewerc,2,\band\bMax\bL\u00f6hninga,b,2\ntion\tfactors \tT-bet \tand\tSTAT4. \tST2\tdeficiency \tresulted \tin\ta\tT-cell\u2013intrinsic\t\nimpairment \tof\tLCMV-specific \tTh1\teffector \tresponses \tin\tboth \tmixed \tbone\t\nmarrow-chimeric \tmice \tand\tadoptive \tcell\ttransfer \texperiments. \tST2-defi -\ncient \tvirus-specific \tCD4+\tTcells \tshowed \timpaired \texpansion, \tTh1\teffector\t\ndifferentiation, \tand\tantiviral \tcytokine \tproduction. \tConsequently, \tthese\t\ncells \tmediated \tlittle \tvirus-induced \timmunopathology. \tThus, \tIL-33 \tacts\tas\t\na\tcritical \tand\tdirect \tcofactor \tto\tdrive \tantiviral \tTh1\teffector \tcell\tactivation,\t\nwith \timplications \tfor\tvaccination \tstrategies \tand\timmunotherapeutic \tap-\nproaches.\na\tExperimental \tImmunology, \tDepartment \tof\tRheumatology \tand\tClinical \tImmunology,\nCharit\u00e9\u2013Universit\u00e4tsmedizin \tBerlin, \t10117 \tBerlin, \tGermany;\nb\tGerman \tRheumatism \tResearch \tCenter \tBerlin, \t10117 \tBerlin, \tGermany;\nc\tDivision \tof\tExperimental \tVirology, \tDepartment \tof\tBiomedicine, \tUniversity \tof\tBasel, \tBasel,\nSwitzerland; \tand\nd\tTranslational \tGastroenterology \tUnit, \tNuffield \tDepartment \tof\tClinical \tMedicine, \tExperimental\t\nMedicine \tDivision, \tJohn \tRadcliffe \tHospital, \tUniversity \tof\tOxford, \tOxford \tOX3\t9DU,\t\nUnited \tKingdom\t\n1\tC.B.\tand\tW.V.B. \tcontributed \tequally \tto\tthis\twork.\t\n2\tD.D.P. \tand\tM.L.\tcontributed \tequally \tto\tthis\twork.\t\nPNAS\b Feb.\b10,\b2015\b|\bvol.\b112\b|\bno.\b6\b|\b1833\u20131838 \b\b IF\b9.809\nThe\textensive \tintratumor \theterogeneity \trevealed \tby\tsequencing \tcancer\t\ngenomes \tis\tan\tessential \tdeterminant \tof\ttumor \tprogression, \tdiagnosis,\t\nand\ttreatment. \tWhat \tmaintains \theterogeneity \tremains \tan\topen \tques -\ntion\tbecause \tcompetition \twithin \ta\ttumor \tleads \tto\ta\tstrong \tselection \tfor\t\nthe\tfittest \tsubclone. \tCancer \tcells \talso\tcooperate \tby\tsharing \tmolecules\t\nwith \tparacrine \teffects, \tsuch \tas\tgrowth \tfactors, \tand\theterogeneity \tcan\t\nbe\tmaintained \tif\tsubclones \tdepend \ton\teach \tother \tfor\tsurvival. \tWithout\t\nstrict \tinterdependence \tbetween \tsubclones, \thowever, \tnonproducer \tcells\t\ncan\tfree-ride \ton\tthe\tgrowth \tfactors \tproduced \tby\tneighboring \tproducer\t\ncells, \ta\tcollective \taction \tproblem \tknown \tin\tgame \ttheory \tas\tthe\t\u201ctragedy\t\nof\tthe\tcommons,\u201d \twhich \thas\tbeen \tobserved \tin\tmicrobial \tcell\tpopulations.\t\nHere, \twe\treport \tthat\tsimilar \tdynamics \toccur \tin\tcancer \tcell\tpopulations.\tHeterogeneity\t for\tIGF-II\t production\t maintained\t by\tpublic\t goods\t dynamics\t in\t\nneuroendocrine\t pancreatic\t cancer\t\nMarco \bArchettia,\bDaniela \bA.\bFerrarob,\band\bGerhard \bChristoforib\na\tSchool \tof\tBiological \tSciences, \tUniversity \tof\tEast\tAnglia, \tNorwich \tResearch \tPark, \tNorwich \tNR4\t\n7TJ,\tUnited \tKingdom; \tand\nb\tDepartment \tof\tBiomedicine, \tUniversity \tof\tBasel, \tCH-4058 \tBasel, \tSwitzerland\t\nNeuroendocrine \tpancreatic \tcancer \t(insulinoma) \tcells \tthat\tdo\tnot\tproduce\t\ninsulin-like \tgrowth \tfactor \tII\t(IGF-II) \tgrow \tslowly \tin\tpure \tcultures \tbut\thave\t\na\tproliferation \tadvantage \tin\tmixed \tcultures, \twhere \tthey \tcan\tuse\tthe\tIGF-\nII\tprovided \tby\tproducer \tcells. \tWe\tshow \tthat, \tas\tpredicted \tby\tevolution -\nary\tgame \ttheory, \tproducer \tcells \tdo\tnot\tgo\textinct \tbecause \tIGF-II \tacts\tas\ta\t\nnonlinear \tpublic \tgood, \tcreating \tnegative \tfrequency-dependent \tselection\t\nthat\tleads \tto\ta\tstable \tcoexistence \tof\tthe\ttwo\tcell\ttypes. \tIntratumor \tcell\t\nheterogeneity \tcan\ttherefore \tbe\tmaintained \teven \twithout \tstrict \tinterde -\npendence \tbetween \tcell\tsubclones. \tReducing \tthe\tamount \tof\tgrowth \tfac-\ntors\tavailable \twithin \ta\ttumor \tmay\tlead\tto\ta\treduction \tin\tgrowth \tfollowed\t\nby\ta\tnew\tequilibrium, \twhich \tmay\texplain \trelapse \tin\ttherapies \tthat\ttarget\t\ngrowth \tfactors.DEPARTMENT \tOF\tBIOMEDICINE\t PUBLICATIONS\t 13\nDBM \tFacts \t2|2015 \t Department \tof\tBiomedicineBlood\b\b March\b2015,\bVol.\b125,\bNumber\b13\b\b IF\b9.775\nThe\tacquired \tsomatic \tJAK2 -V617F \tmutation \tis\tpresent \tin\t>80% \tof\tpa-\ntients \twith \tmyeloproliferative \tneoplasms \t(MPNs). \tStat3 \tplays \ta\trole\tin\t\nhematopoietic \thomeostasis \tand\tmight \tinfluence \tthe\tJAK2 -V617F\u2013driven\t\nMPN \tphenotype. \tWe\tcrossed \tour\ttransgenic \tSclCre;V617F \tmice \twith \ta\t\nconditional \tStat3 \tknockout \tstrain \tand\tperformed \tbone \tmarrow \ttrans -\nplantations \tinto\tlethally \tirradiated \trecipient \tmice. \tThe\tdeletion \tof\tStat3 \nincreased \tthe\tplatelet \tnumbers \tin\tSclCre;V617F;Stat3fl/fl\tmice \tcompared\t\nwith \tSclCre;V617F;Stat3fl/+\tor\tSclCre;V617F;Stat3+/+\tmice. \tStat3 \tdeletion\t\nalso\tnormalized \tJAK2 -V617F\u2013induced \tneutrophilia. \tMegakaryocyte \tpro-\ngenitors \twere \televated, \tespecially \tin\tthe\tspleen, \tand\ta\tslight \tincrease \tin\tmyelofibrosis \twas\tnoted. \tWe\tobserved \tincreased \tmRNA \texpression \tlev-\nels\tof\tStat1 \tand\tStat1 \ttarget \tgenes \tand\taugmented \tphosphorylation \tof\t\nStat1 \tprotein \tin\tbone \tmarrow \tand\tspleen \tof\tJAK2 -V617F \tmice \tafter \tStat3\t\ndeletion. \tThe\tsurvival \tof\tStat3 -deficient \tmice \texpressing \tJAK2 -V617F \twas\t\nreduced. \tInflammatory \tbowel \tdisease, \tpreviously \tassociated \twith \tshort -\nened \tsurvival \tof\tStat3 -deficient \tmice, \twas\tless\tprominent \tin\tthe\tbone\t\nmarrow \ttransplantation \tsetting, \tpossibly \tby\tlimiting \tdeletion \tof\tStat3 \tto\t\nhematopoietic \ttissues \tonly. \tIn\tconclusion, \tdeletion \tof\tStat3 \tin\themato -\npoietic \tcells \tfrom \tJAK2 -V617F \tmice \tdid\tnot\tameliorate \tthe\tcourse \tof\tMPN,\t\nbut\trather \tenhanced \tthrombocytosis \tand\tshortened \tthe\toverall \tsurvival.\tDeletion\t of\tStat3\t in\thematopoietic\t cells\t enhances\t thrombocytosis\t and\nshortens\t survival\t in\ta\tJAK2-V617F\t mouse\t model\t of\tMPN\t\nJean \bGrisouard1,\bTakafumi \bShimizu1,\bAdrian \bDuek1,\bLucia \bKubovcakova1,\bHui\bHao-Shen1,\bStephan \bDirnhofer2,\nand\bRadek \bC.\bSkoda1\n1\tDepartment \tof\tBiomedicine, \tExperimental \tHematology, \tand\n2\tInstitute \tof\tPathology, \tUniversity \tHospital \tBasel, \tBasel, \tSwitzerland\t\nDiabetes\b 2015;64:1273\u20131283\b \b IF\b8.474\n1\tClinic \tof\tEndocrinology, \tDiabetes, \tand\tMetabolism, \tUniversity \tHospital \tBasel, \tBasel, \tSwitzerland\n2\tDepartment \tof\tBiomedicine, \tUniversity \tof\tBasel, \tBasel, \tSwitzerland\n3\tCell\tIsolation \tand\tTransplantation \tCenter, \tDepartment \tof\tSurgery, \tGeneva \tUniversity \tHospitals,\t\nGeneva, \tSwitzerland\n4\tUniversity \tof\tGeneva \tSchool \tof\tMedicine, \tGeneva, \tSwitzerland\n5\tUniversity \tLille\tNord \tde\tFrance, \tLille, \tFrance\n6\tClinic \tfor\tTransplantation \tImmunology \tand\tNephrology, \tUniversity \tHospital \tBasel, \tBasel,\nSwitzerlandAngiotensin\t II\tInduces\t lnterleukin-1\u03b2-Mediated\t Islet\t Inflammation\t and\t\u03b2-Cell\t\nDysfunction\t Independently\t of\tVasoconstrictive\t Effects\nNadine \bS.\bSauter1,2,\bConstanze \bThienel1,2,\bYuliya \bPlutino1,\bKapil \bKampe2,\bErez \bDror1,2,\bShuyang \bTraub1,2,\bKatharina \bTimper1,2,\nBenoit \bB\u00e9dat3,4,\bFrancois \bPattou5,\bJulie \bKerr-Conte5,\bAndreas \bW.\bJehle2,6,\bMarianne \bB\u00f6ni-Schnetzler1,2\band\bMarc \bY.\bDonath1,2\b\nPathological \tactivation \tof\tthe\trenin-angiotensin \tsystem \t(RAS) \tis\tassoci -\nated \twith \tthe\tmetabolic \tsyndrome, \tand\tthe\tnew\tonset \tof\ttype \t2\tdiabetes\t\ncan\tbe\tdelayed \tby\tRAS\tinhibition. \tIn\tanimal \tmodels \tof\ttype \t2\tdiabetes,\t\ninhibition \tof\tthe\tRAS\timproves \tinsulin \tsecretion. \tHowever, \tthe\tdirect \tef-\nfects \tof\tangiotensin \tII\ton\tislet\tfunction \tand\tunderlying \tmechanisms \tinde -\npendent \tof\tchanges \tin\tblood \tpressure \tremain \tunclear. \tHere \twe\tshow \tthat\t\nexposure \tof\thuman \tand\tmouse \tislets \tto\tangiotensin \tII\tinduces \tinterleukin\t\n(IL)-1-dependent \texpression \tof\tIL-6\tand\tMCP-1, \tenhances \t\u03b2-cell\tapop -\ntosis, \tand\timpairs \tmitochondrial \tfunction \tand\tinsulin \tsecretion. \tIn\tvivo,\tmice \tfed\ta\thigh-fat \tdiet\tand\ttreated \twith \tangiotensin \tII\tand\tthe\tvasodilator\t\nhydralazine \tto\tprevent \thypertension \tshowed \tdefective \tglucose-stimulat -\ned\tinsulin \tsecretion \tand\tdeteriorated \tglucose \ttolerance. \tApplication \tof\tan\t\nanti-IL-1 \t\u03b2\tantibody \treduced \tthe\tdeleterious \teffects \tof\tangiotensin \tII\ton\t\nislet\tinflammation, \trestored \tinsulin \tsecretion, \tand\timproved \tglycemia.\t\nWe\tconclude \tthat \tangiotensin \tII\tleads \tto\tislet \tdysfunction \tvia\tinduction \tof\t\ninflammation \tand\tindependent \tof\tvasoconstriction. \tOur\tfindings \treveal\t\na\tnovel \trole\tfor\tthe\tRAS\tand\tan\tadditional \trationale \tfor\tthe\ttreatment \tof\t\ntype \t2\tdiabetic \tpatients \twith \tan\tIL-1\t\u03b2\tantagonist.\n14\t PUBLICATIONS \t DEPARTEMENT \tBIOMEDIZIN\nDBM \tFacts \t2|2015 \t Departement \tBiomedizinCytotoxic \tdrugs \tcapable \tof\tkilling \tcancer \tcells \tin\tconjunction \twith \ttar-\ngeted \tconversion \tof\ttumor \tresident, \ttolerogenic \tdendritic \tcells \t(DCs) \tinto\t\nefficient \tantigen \tpresenting \tcells \t(APCs) \tare\thighly \tcomplementary \tthera -\npeutic \troutes \tto\tboost \tantitumor \timmunity. \tOur\tdata\tsuggest \tthat\tthe\t\nmicrotubule-depolymerizing \tcompounds \tDolastatin \t10\tand\tAnsamitocin\t\nP3\tmay\tserve \tas\tprototypes \tfor\ta\tclass \tof\tagents \tthat\tdisplay \tthis\tbinary\t\nmode \tof\taction.\t\nThe\tfield\tof\tcancer \timmunotherapy \tis\tmoving \tforward \tat\tan\taccelerated\t\npace \tand\twas\thonorably \tselected \tas\tBreakthrough \tof\tthe\tYear\tin\t2013 \tby\t\nthe\teditors \tof\tScience. \tFollowing \tmany \tdisappointments \tand\tdecades\t\nlong \tstruggles \tto\tsuccessfully \timplement \tcancer \timmunotherapy \tfrom\t\nthe\tbench \tto\tthe\tbedside \tthe\tconcerted \tefforts \tof\tbasic \tand\tclinical \tsci-entists \thave \tbegun \tto\tpay\toff\tin\tthe\tform \tof\tefficacious \tclinical \ttreatment\t\nregimens. \tIpilimumab, \ta\tfully \thumanized \tantibody \ttargeting \tcytotoxic \tT\t\nlymphocyte \tassociated \tprotein \t4\t(CTLA-4) \tas\twell\tas\tanti-PD-1 \tand\t-PD-\nL1\t(the\tligand \tof\tPD-1) \tblocking \tantibodies \ttargeting \tthe\tprogrammed\t\ncell\tdeath \t1\t(PD-1) \timmune \tcheckpoint, \thave \tstimulated \tobjective \tand\t\ndurable \tanticancer \tresponses \tin\tpatients \twith \ttreatment-refractory \tsolid\t\ntumors, \tincluding \tmelanoma \tand\tcancers \tof\tthe\tlung, \tand\tkidney. \tThese\t\nclinical \tsuccesses \thighlight \tthe\tpotential \tof\timmune-based \ttherapies \tin\t\noncology. \tNevertheless, \tonly\ta\tfraction \tof\tpatients \trespond \tand\tmost \tof\t\nthe\tresponders \teventually \trelapse. \tPossible \texplanations \tinclude \timmune\t\neffector \tcell\tpaucity \tat\tthe\ttumor \tsite,\tas\twell\tas\tthe\tmolecular \tand\tcellular\t\ncomposition \tof\tthe\ttumor \tmicroenvironment, \tboth \tof\twhich \tmay\tpose \ta\t\nmajor \thurdle \tfor\tcontriving \tantitumor \timmunity.OncoImmunology\b 3:8,\be954460;\bAugust\b1,\b2014\b IF\b6.283\nCancer\t chemotherapy\t agents\t target\t intratumoral\t dendritic\t cells\t to\tpotentiate\t\nantitumor\t immunity\t\nPhilipp \bM\u00fcller1,\bKea\bMartin1,\bSebastian \bTheurich2,\bMichael \bvon\bBergwelt-Baildon2,\band\bAlfred \bZippelius1,3\n1\tCancer \tImmunology \t&\tBiology; \tDepartment \tof\tBiomedicine; \tUniversity \tHospital \tBasel \tand\t\nUniversity \tof\tBasel; \tSwitzerland;\n2\tDepartment \tI\tof\tInternal \tMedicine \tand\tCologne \tInterventional \tImmunology; \tUniversity \tHospital\t\nCologne; \tGermany;\n3\tDepartment \tof\tMedical \tOncology; \tUniversity \tHospital \tBasel; \tSwitzerland\t\nThe\bJournal\bof\bInfectious\bDiseases\b 2015;211:1251\u201361\b \b IF\b5.778\nBackground. \tAspergillus \tand\tMucorales \tspecies \tcause \tsevere \tinfections\t\nin\tpatients \tafter \thematopoietic \tstem \tcell\ttransplantation \t(HSCT). \tInduc -\ntion\tof\tantifungal \tCD4+\tT-helper \ttype \t1\t(Th1)\timmunity \tis\tan\tappealing\t\nstrategy \tto\tcombat \tthese \tinfections. \tImmunotherapeutic \tapproaches \tare\t\nso\tfar\tlimited \tbecause \tof\ta\tlack\tof\tantigens \tinducing \tprotective \tT\tcells,\t\ntheir \telaborate \tproduction, \tand\tthe\tneed \tof\ttargeting \ta\tbroad \tspectrum\t\nof\tpathogenic \tfungi.\t\nMethods. \tWe\texamined \tthe\tresponse \tto\tdifferent \tAspergillus fumigatus\t\nproteins \tin\thealthy \tindividuals \tand\tpatients \tafter \tHSCT \tand\tcompared\t\nrapid \tselection \tprotocols \tfor\tfungus-speci fic\tT\tcells \tbased \ton\tCD137 \tor\t\nCD154 \texpression.\tResults. \tThe\tA. fumigatus \tproteins \tCrf1, \tGel1, \tand\tPmp20 \tinduced\t\nstrong \tTh1\tresponses \tin\thealthy \tindividuals. \tT\tcells \tspeci fic\tfor\tthese \tan-\ntigens \texpanded \tin\tpatients \twith \tactive \tinvasive \taspergillosis, \tindicating\t\ntheir \tcontribution \tto\tinfection \tcontrol. \tTh1\tcells \tspeci fic\tfor\tthe\t3\tproteins\t\ncan\tbe\tselected \twith \tsimilar \tspeci ficity\twithin \t24\thours, \tbased \ton\tCD137\t\nor\tCD154 \texpression. \tThese \tcells \trecognize \tnaturally \tprocessed \tA. fu -\nmigatus \tand\tthe\tmultispeci fic\tT-cell \tlines, \tdirected \tagainst \tall\t3\tproteins,\t\nespecially \tthose \tselected \tby\tCD154, \tadditionally \tcross-react \tto\tdifferent\t\nAspergillus and\tMucorales \tspecies.\t\nConclusions. \tThese \t findings \tmay\tform \tthe\tbasis \tfor\tadoptive \tT-cell\t\ntransfer \tfor\tprophylaxis \tor\ttreatment \tin\tpatients \twith \tthese \tdevastating\t\ninfections.\tMultispecific\t Aspergillus\t T\tCells\t Selected\t by\tCD137\t or\tCD154\t Induce\t Protective\t\nImmune\t Responses\t Against\t the\tMost\t Relevant\t Mold\t Infections\t\nClaudia \bStuehler1,\bJustyna \bNowakowska1,\bClaudia \bBernardini1,2,\bMax\bS.\bTopp4,\bManuel \bBattegay2,\bJakob \bPassweg3,\nand\bNina \bKhanna1,2\b\n1\tInfection \tBiology \tLaboratory, \tDepartment \tof\tBiomedicine,\n2\tDivision \tof\tInfectious \tDiseases \tand\tHospital \tEpidemiology, \tDepartments \tof\tBiomedicine \tand\t\nClinical \tResearch, \tand\n3\tDivision \tof\tHematology, \tUniversity \tHospital \tof\tBasel, \tSwitzerland; \tand\n4\tDivision \tof\tHematology, \tDepartment \tof\tInternal \tMedicine \tII,\tUniversity \tof\tWuerzburg, \tGermany\nDEPARTMENT \tOF\tBIOMEDICINE\t PUBLICATIONS\t 15\nDBM \tFacts \t2|2015 \t Department \tof\tBiomedicineEuropean\bNeuropsychopharmacology \b\b (2015)\b25,\b365\u2013376\b \b IF\b5.395\nAbstract\t\nThe\tpharmacology \tof\tnovel \tpsychoactive \tsubstances \tis\tmostly \tun-\nknown. \tWe\tevaluated \tthe\ttransporter \tand\treceptor \tinteraction \tprofiles\t\nof\ta\tseries \tof\tpara-(4)-substituted \tamphetamines \tand\tpyrovalerone\t\ncathinones. \tWe\ttested \tthe\tpotency \tof\tthese \tcompounds \tto\tinhibit \tthe\t\nnorepinephrine \t(NE), \tdopamine \t(DA), \tand\tserotonin \t(5-HT) \ttransporters\t\n(NET, \tDAT, \tand\tSERT, \trespectively) \tusing \thuman \tembryonic \tkidney \t293\t\ncells \tthat\texpress \tthe\trespective \thuman \ttransporters. \tWe\talso\ttested \tthe\t\nsubstance-induced \tefflux\tof\tNE,\tDA,\tand\t5-HT \tfrom \tmonoamine-loaded\t\ncells, \tbinding \taffinities \tto\tmonoamine \treceptors, \tand\t5-HT 2B\treceptor \tac-\ntivation. \tPara-(4)-substituted \tamphetamines, \tincluding \t4-methylmeth -\ncathinone \t(mephedrone), \t4-ethylmethcathinone, \t4-fluoroamphetamine,\t\n4-fluoromethamphetamine, \t4-fluoromethcatinone \t(flephedrone), \tand\t\n4-bromomethcathinone, \twere \trelatively \tmore \tserotonergic \t(lower\t\nDAT:SERT \tratio) \tcompared \twith \ttheir \tanalogs \tamphetamine, \tmethamphet -\namine, \tand\tmethcathinone. \tThe\t4-methyl, \t4-ethyl, \tand\t4-bromo \tgroups\tresulted \tin\tenhanced \tserotonergic \tproperties \tcompared \twith \tthe\t4-fluoro\t\ngroup. \tThe\tpara-substituted \tamphetamines \treleased \tNE\tand\tDA.\t4-Flu -\noramphetamine, \t4-flouromethamphetamine, \t4-methylmethcathinone,\t\nand\t4-ethylmethcathinone \talso\treleased \t5-HT \tsimilarly \tto\t3,4-methyl -\nenedioxymethamphetamine. \tThe\tpyrovalerone \tcathinones \t3,4-methy -\nlenedioxypyrovalerone, \tpyrovalerone, \t\u03b1-pyrrolidinovalerophenone,\t\n3,4-methylenedioxy- \u03b1-pyrrolidinopropiophenone, \tand\t3,4-methylene-\ndioxy-\u03b1-pyrrolidinobutiophenone \tpotently \tinhibited \tthe\tNET\tand\tDAT\t\nbut\tnot\tthe\tSERT. \tNaphyrone \twas\tthe\tonly\tpyrovalerone \tthat\talso\tinhib -\nited\tthe\tSERT. \tThe\tpyrovalerone \tcathinones \tdid\tnot\trelease \tmonoamines.\t\nMost \tof\tthe\tpara-substituted \tamphetamines \texhibited \taffinity\tfor\tthe\t\n5-HT 2A\treceptor \tbut\tno\trelevant \tactivation \tof\tthe\t5-HT 2B\treceptor. \tAll\tthe\t\ncathinones \texhibited \treduced \ttrace \tamine-associated \treceptor \t1\tbinding\t\ncompared \twith \tthe\tnon-\u03b2-keto-amphetamines.Monoamine\t transporter\t and\treceptor\t interaction\t profiles\t of\tnovel\npsychoactive\t substances:\t Para-halogenated\t amphetamines\t and\npyrovalerone\t cathinones\t\nAnna \bRicklia,\bMarius \bC.\bHoenerb,\bMatthias \bE.\bLiechtia\na\tPsychopharmacology \tResearch, \tDivision \tof\tClinical \tPharmacology \tand\tToxicology, \tDepartment\t\nof\tBiomedicine, \tUniversity \tHospital \tBasel \tand\tUniversity \tof\tBasel, \tBasel, \tSwitzerland\nb\tPharmaceuticals \tDivision, \tF.\tHoffmann-La \tRoche \tLtd., \tBasel, \tCH-4070, \tSwitzerland\t\nHuman\bMutation\b 36:250\u2013259,\b2015\b \b IF\b5.112\nAbstract: \tAlthough \tmost \tof\tthe\tpertinent \tdata\ton\tthe\tsequence-direct -\ned\tprocesses \tleading \tto\tgenome \trearrangements \t(GRs) \thave \tcome \tfrom\t\nstudies \ton\tsomatic \ttissues, \tlittle \tis\tknown \tabout \tGRs\tin\tthe\tgerm \tline\tof\t\npatients \twith \thereditary \tdisorders. \tThis\tstudy \taims \tat\tidentifying \tDNA\t\nmotifs \tand\thigher \torder \tstructures \tof\tgenome \tarchitecture, \twhich \tcan\t\nresult \tin\tlosses \tand\tgains \tof\tgenetic \tmaterial \tin\tthe\tgerm \tline.\tWe\t first\t\nidenti fied\tcandidate \tmotifs \tby\tstudying \t112\tpathogenic \tgerm-line \tGRs\t\nin\thereditary \tcolorectal \tcancer \tpatients, \tand\tsubsequently \tcreated \tan\tal-\ngorithm, \ttermed \trecombination \ttype \tratio, \twhich \tcorrectly \tpredicts \tthe\t\npropensity \tof\trearrangements \twith \trespect \tto\thomologous \tversus \tnon-\nhomologous \trecombination \tevents.\t\nIntroduction\bComputational \tbiology \tis\tlikely \tto\tbe\tinstrumental \tin\trefining \tour\tunder -\nstanding \tof\tthe\tdesign \tof\tnatural \tbiological \tsystems. \tThis\tscienti fic\tdisci -\npline \tassumes \ta\tblock-based \tstructure \tof\tgenomes \tof\tliving \torganisms,\tsuch \tthat\tbiological \tfunctions \tare\tencoded \tin\tshorter \tDNA \tmotifs \tthat\tare\t\nselected \tthrough \tevolution. \tAs\tevolution \tcannot \texist \twithout \tan\tadapta -\ntion, \tit\tis\talso\texpected \tthat\tsome \tDNA \tmotifs \tevolved \tto\tgenerate \tdiver -\nsity\tof\tstructures \ton\twhich \tselection \tcould \toperate.\tHigh-Resolution\t Breakpoint\t Analysis\t Provides\t Evidence\t for\tthe\tSequence-\nDirected\t Nature\t of\tGenome\t Rearrangements\t in\tHereditary\t Disorders\t\nMichal \bB.\bKovac1,2,3,*,\bMonika \bKovacova4,*,\bHynek \bBachraty5,\bKatarina \bBachrata6,\bSalvatore \bPiscuoglio1,2,7,\bPierre \bHutter8,\nDenisa \bIlencikova9,\bZdena \bBartosova10,\bIan\bTomlinson3,\bBenno \bRoethlisberger11,\band\bKarl\bHeinimann1,2\n1\t\tResearch \tGroup \tHuman \tGenomics, \tDepartment \tof\tBiomedicine, \tUniversity \tof\tBasel, \tBasel,\n\tSwitzerland;\n2\tMedical \tGenetics, \tUniversity \tHospital \tBasel, \tBasel, \tSwitzerland;\n3\tThe\tWellcome \tTrust \tCentre \tfor\tHuman \tGenetics, \tUniversity \tof\tOxford, \tOld\tRoad \tCampus,\t\nOxford, \tUK;\n4\tInstitute \tof\tMathematics \tand\tPhysics, \tFaculty \tof\tMechanical \tEngineering, \tSlovak \tUniversity \tof\t\nTechnology, \tBratislava, \tSlovakia;\n5\tDepartment \tof\tSoftware \tTechnologies, \tFaculty \tof\tManagement \tScience \tand\tInformatics, \tUniver -\nsity\tof\tZilina, \tZilina, \tSlovakia;\n6\tDepartment \tof\tInfoCom \tNetworks, \tFaculty \tof\tManagement \tScience \tand\tInformatics, \tUniversity\t\nof\tZilina, \tZilina, \tSlovakia;\n7\tDepartment \tof\tPathology, \tMemorial \tSloan-Kettering \tCancer \tCenter, \tNew \tYork\tCity, \tNew \tYork;\n8\tInstitut \tCentral \tdes\tHopitaux \tValaisans, \tService \tde\tG\u00e9n\u00e9tique \tM\u00e9dicale, \tSion, \tSwitzerland;\n9\tPediatric \tDepartment, \tUniversity \tChildren \tHospital, \tComenius \tUniversity, \tBratislava, \tSlovakia;\n10\tMedical \tGenetics, \tSt.\tElizabeth \tCancer \tInstitute, \tBratislava, \tSlovakia;\n11\tKantonsspital \tAarau, \tTellstrasse, \tAarau, \tSwitzerland\t\n*\tThese \tauthors \tcontributed \tequally \tto\tthis\twork.\n16\t PUBLICATIONS \t DEPARTEMENT \tBIOMEDIZIN\nDBM \tFacts \t2|2015 \t Departement \tBiomedizinJAMA\b Dermatology\b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b 2015;151(1):64\u201369\b \b IF\b5.004\nImportance \tIchthyosis \twith \tconfetti \t(IWC) \tis\ta\tgenodermatosis \tcaused\t\nby\tdominant \tnegative \tmutations \tin\tthe\tgene \tencoding \tkeratin \t10\t(KRT10) .\t\nWe\tinvestigated \tclinical \tand\tgenetic \tdetails \tof\ta\tsubstantial \tnumber \tof\tpa-\ntients \twith \tIWC\tin\torder \tto\tdefine \tmajor \tand\tminor \tcriteria \tfor\tdiagnosis\t\nof\tthis\trare\tdisorder.\t\nObservations \tParallel \tclinical \tinvestigation \tof\t6\tpatients \twith \tIWC\tre-\nvealed \ta\tnovel \tspectrum \tof\tphenotypes. \tWe\tfound \tseveral \tfeatures \tthat\t\nqualify \tas\tmajor \tcriteria \tfor\tdiagnosis, \twhich \tare\tclearly \tand\tconsistently\t\nassociated \twith \tthe\tcondition. \tThese \tincluded \tmalformation \tof\tears, \thy-\npoplasia \tof\tmammillae, \tand\tdorsal \tacral \thypertrichosis. \tGenetic \tanalysis\tof\tpatients \trevealed \tseveral \tdifferent \tframeshift \tmutations \tin\tintron \t6\tor\t\nexon \t7\tof\tKRT10 .\tAnalysis \tof\tthis\tlocus \tin\t17\tunrelated \tcontrol \tindividuals\t\nrevealed \t2\tnovel \tpolymorphisms \tof\tKRT10 .\t\nConclusions \band\bRelevance \tWe\tpresent \tfor\tthe\tfirst\ttime \tto\tour\tknowl -\nedge \tthe\tspectrum \tof\tclinical \tvariability \tof\tIWC\tin\t6\tpatients \twith \tcon-\nfirmed \tmutations \tin\tKRT10 .\tFrom \tthis,\twe\thave \textracted \tmajor \tand\tminor\t\ncriteria \tto\taid\tearly \tand\tcorrect \tclinical \tdiagnosis. \tEctodermal \tmalforma -\ntions, \tpresent \tin\tall\tpatients, \tsuggest \ta\tnovel \tclassification \tof\tIWC\tas\ta\t\nsyndrome. \tThere \tis\tremarkable \tgenetic \tvariation \tat\tthe\tIWC\tdisease \tlocus\t\nwithin \tcontrol \tindividuals \tfrom \tthe\tgeneral \tpopulation.\tThe\tPhenotypic\t and\tGenotypic\t Spectra\t of\tIchthyosis\nWith\t Confetti\t Plus\t Novel\t Genetic\t Variation\t in\tthe\t3\u00b4\tEnd\tof\tKRT10\t\nFrom\t Disease\t to\ta\tSyndrome\t\nAuthor \tAffiliations:\nResearch\tGroup\tof\tDermatology,\tDepartment\tof\tBiomedicine,\tUniversity\tHospital\tBasel,\tBasel,\t\nSwitzerland\t(Spoerri,\tDe\tMesmaeker,\tBurger);\nSection\t of\tDermatology,\t Fondazione\t IRCCS\t C\u00e0\tGranda,\t Ospedale\t Maggiore\t Policlinico\t di\tMilano,\t De-\npartment\tof\tPathophysiology\tand\tTransplantation,\tUniversity\tof\tMilan,\tMilan,\tItaly\t(Brena,\tTadini);\t\nDermatology,\tUniversity\tHospital\tBasel,\tBasel,\tSwitzerland\t(Itin);\nInstitute\tof\tHuman\tGenetics,\tUniversity\tMedical\tCenter\tFreiburg,\tFreiburg,\tGermany\t(Schlipf,\tFischer).\nBiochemical\bJournal\b (2015)\b466,\b123\u2013135\b \b IF\b4.779\nThe\tprotein \tmammalian \ttarget \tof\trapamycin \t(mTOR) \tis\ta\tserine/threo -\nnine \tkinase \tregulating \ta\tnumber \tof\tbiochemical \tpathways \tcontrolling \tcell\t\ngrowth. \tmTOR \texists \tin\ttwo\tcomplexes \ttermed \tmTORC1 \tand\tmTORC2.\t\nRegulatory \tassociated \tprotein \tof\tmTOR \t(raptor) \tis\tassociated \twith\t\nmTORC1 \tand\tis\tessential \tfor\tits\tfunction. \tAblation \tof\traptor \tin\tskeletal\t\nmuscle \tresults \tin\tseveral \tphenotypic \tchanges \tincluding \tdecreased \tlife\tex-\npectancy, \tincreased \tglycogen \tdeposits \tand\talterations \tof\tthe\ttwitch \tkinet -\nics\tof\tslow \tfibres. \tIn\tthe\tpresent \tpaper, \twe\tshow \tthat\tin\tmuscle-speci fic\t\nraptor \tknockout \t(RamKO), \tthe\tbulk\tof\tglycogen \tphosphorylase \t(GP)\tis\t\nmainly \tassociated \tin\tits\tcAMP-non-stimulated \tform \twith \tsarcoplasmic\t\nreticulum \t(SR)\tmembranes. \tIn\taddition, \t3[H]\u2013ryanodine \tand\t3[H]\u2013PN200-110\tequilibrium \tbinding \tshow \ta\tryanodine \tto\tdihydropyridine \treceptors\t\n(DHPRs) \tratio \tof\t0.79 \tand\t1.35\tfor\twild-type \t(WT) \tand\traptor \tKO\tskeletal\t\nmuscle \tmembranes \trespectively. \tPeak \tamplitude \tand\ttime \tto\tpeak \tof\tthe\t\nglobal \tcalcium \ttransients \tevoked \tby\tsupramaximal \tfield\tstimulation \twere\t\nnot\tdifferent \tbetween \tWT\tand\traptor \tKO.\tHowever, \tthe\tincrease \tin\tthe\t\nvoltage \tsensor-uncoupled \tRyRs \tleads \tto\tan\tincrease \tof\tboth \tfrequency\t\nand\tmass \tof\telementary \tcalcium \trelease \tevents \t(ECRE) \tinduced \tby\thyper-\nosmotic \tshock \tin\tflexor \tdigitorum \tbrevis \t(FDB) \tfibres\tfrom \traptor \tKO.\tThe\t\npresent \tstudy \tshows \tthat\tthe\tprotein \tcomposition \tand\tfunction \tof\tthe\t\nmolecular \tmachinery \tinvolved \tin\tskeletal \tmuscle \texcitation\u2013contraction\t\n(E\u2013\tC)\tcoupling \tis\taffected \tby\tmTORC1 \tsignalling.\tRaptor\t ablation\t in\tskeletal\t muscle\t decreases\t Cav1.1\t expression\t and\taffects\t the\t\nfunction\t of\tthe\texcitation\u2013contraction\t coupling\t supramolecular\t complex\t\nRub\u00e9n \bJ.\bLopez1,\bBarbara \bMosca1,2,\bSusan \bTreves1,2,\bMarcin \bMaj1,\bLeda \bBergamelli2,\bJuan \bC.\bCalderon3,\bC.\bFlorian \bBentzinger4,\nKlaas \bRomanino4,\bMichael \bN.\bHall4,\bMarkus \bA.R\u00fcegg4,\bOsvaldo \bDelbono5,\bCarlo \bCaputo3\band\bFrancesco \bZorzato1,2\b\n1\tDepartments \tof\tAnesthesia \tand\tof\tBiomedicine, \tBasel \tUniversity \tHospital, \tHebelstrasse \t20,\n\t 4031 \tBasel, \tSwitzerland\t\n2\tDepartment \tof\tLife\tSciences, \tGeneral \tPathology \tsection, \tUniversity \tof\tFerrara, \tVia\tBorsari \t46,\t\n44100 \tFerrara, \tItaly\t\n3\tLaboratorio \tde\tFisiolog\u00eda \tCelular, \tCentro \tde\tBiof\u00edsica \ty\tBioqu\u00edmica, \tInstituto \tVenezolano \tde\t\nInvestigaciones \tCient\u00ed ficas\t(IVIC), \tApartado \t20632, \t1020A \tCaracas, \tVenezuela\n4\tBiozentrum, \tUniversity \tof\tBasel, \tCH-4056 \tBasel, \tSwitzerland\n5\tDepartment \tof\tInternal \tMedicine, \tSection \ton\tGerontology \tand\tGeriatric \tMedicine, \tWake \tForest\t\nUniversity \tSchool \tof\tMedicine, \tWinston-Salem, \tNC\t27157, \tU.S.A.\tIris\bSpoerri, \bPhD; \bMichela \bBrena, \bMD;\bJulie \bDe\bMesmaeker, \bPhD; \bNina \bSchlipf, \bPhD; \bJudith \bFischer, \bMD,\bPhD;\b\nGianluca \bTadini, \bMD;\bPeter \bH.\bItin,\bMD;\bBettina \bBurger, \bPhD\b\nDEPARTMENT \tOF\tBIOMEDICINE\t PUBLICATIONS\t 17\nDBM \tFacts \t2|2015 \t Department \tof\tBiomedicineExcitation\u2013contraction \tcoupling \t(ECC) \tis\tthe\tphysiological \tmechanism\t\nwhereby \tan\telectrical \tsignal \tdetected \tby\tthe\tdihydropyridine \treceptor, \tis\t\nconverted \tinto\tan\tincrease \tin\t[Ca2\t+\t],\tvia\tactivation \tof\tryanodine \treceptors\t\n(RyRs). \tMutations \tin\tRYR1 ,the\tgene \tencoding \tRyR1, \tare\tthe\tunderlying\t\ncause \tof\tvarious \tcongenital \tmyopathies \tincluding \tcentral \tcore \tdisease,\t\nmultiminicore \tdisease \t(MmD), \tsome \tforms \tof\tcentronuclear \tmyopathy\t\n(CNM) \tand\tcongenital \t fibre-type \tdisproportion. \tInterestingly, \tpatients\t\nwith \trecessive, \tbut\tnot\tdominant, \tRYR1 \tmutations \tshow \ta\tsigni ficant\t\nreduction \tin\tRyR\tprotein \tin\tmuscle \tbiopsies \tas\twell\tas\tophthalmoplegia.\tBiochemical\bJournal\b (2015)\b466,\b29\u201336\b \b IF\b4.779\nThis\tspeci fic\tinvolvement \tof\tthe\textraocular \tmuscles \t(EOMs) \tindicates\t\nthat\tthis\tgroup \tof\tmuscles \tmay\texpress \tdifferent \tamounts \tof\tproteins\t\ninvolved \tin\tECC\tcompared \twith \tlimb \tmuscles. \tIn\tthe\tpresent \tpaper, \twe\t\nreport \tthat\tthis\tis\tindeed \tthe\tcase; \tin\tparticular \tthe\ttranscripts \tencoding\t\nRyR3, \tcardiac \tcalsequestrin \t(CSQ2) \tand\tthe\t\u03b11subunit \tof\tthe\tcardiac \tdi-\nhydropyridine \treceptor \tare\tup-regulated \tby\tat\tleast \t100-fold, \twhereas\t\nexcitation-coupled \tCa2\t+\tentry \tis\t3-fold \thigher. \tThese \tfindings \tsupport \tthe\t\nhypothesis \tthat\tEOMs \thave \ta\tunique \tmode \tof\tcalcium \thandling.\t\n1\tDepartments \tof\tAnesthesia \tand\tBiomedizin, \tBasel \tUniversity \tHospital, \tHebelstrasse \t20,\n4031 \tBasel, \tSwitzerland\t\n2\tEye\tHospital, \tBasel \tUniversity \tHospital, \tMittlere \tStrasse \t91,\t4031Basel, \tSwitzerland\t\n3\tDepartment \tof\tLife\tSciences \tand\tBiotechnology, \tGeneral \tPathology \tsection, \tUniversity \tof\nFerrara, \tVia\tBorsari \t46,\t44100 \tFerrara, \tItaly\tCharacterization\t of\texcitation\u2013contraction\t coupling\ncomponents\t in\thuman\t extraocular\t muscles\t\nMarijana \bSekulic-Jablanovic1,\bAnja \bPalmowski-Wolfe2,\bFrancesco \bZorzato1,3,\band\bSusan \bTreves1,3\b\nJournal\bof\bVirology\b April\b2015,\bVol.\b89,\bNo.\b7\b \b IF\b4.648\nCytotoxic-T \tlymphocyte \t(CTL) \tresponses \tto\tepitopes \tin\talternative \tHIV\t\nreading \tframes \thave \tbeen \treported. \tHowever, \tthe\textent \tof\tCTL\trespons -\nes\tto\tputative \tproteins \tencoded \tin\tantisense \treading \tframes \tis\tunknown.\t\nUsing \tsequence \talignments \tand\tcomputational \tapproaches, \twe\there \tpre-\ndict\tfive\tpotential \tantisense \tHIV\tproteins \tand\tcharacterize \tcommon \tCTL\t\nresponses \tagainst \tthem. \tResults \tsuggest \tthat\tantisense-derived \tsequenc -\nes\tare\tcommonly \ttranscribed \tand\ttranslated \tand\tcould \tencode \tfunctional\t\nproteins \tthat\tcontain \timportant \ttargets \tof\tanti-HIV \tcellular \timmunity.\t\nVirus-speci fic\tCD8+\tcytotoxic-T \tlymphocyte \t(CTL) \tresponses \tare\timpor -\ntant\tin\tthe\tcontrol \tof\tHIV\tinfection \t(1\u20133). \tAccumulating \tevidence \tindi-\ncates \tthat\tin\taddition \tto\tCTL\tresponses \ttargeting \tknown \tstructural \tand\tnonstructural \tHIV\tproteins, \tCTL\tresponses \tto\tepitopes \tin\talternative \tread -\ning\tframes \t(ARFs) \tof\tHIV\tcan\tcontribute \tto\tin vivo \timmune \tselection \tpres-\nsure\t(4\u20136). \tImportantly, \tthese \tCTL\tresponses \tare\tnot\tlimited \tto\tARFs \tin\t\nthe\tsense \tdirection, \tbut\tmay\talso\ttarget \tantisense-encoded \tARFs \t(5,\t6).\t\nAntisense \ttranscription \tof\tknown \thost \tgenes \tin\thuman \tand\trodent \tcells\t\nhas\tbeen \textensively \tdescribed \t(7\u201310), \tand\tthe\texistence \tof\tan\tantisense\t\nprotein \t(ASP) \tin\tHIV\twas\tfirst\tproposed \tmore \tthan \t20\tyears \tago\t(10\u201312).\t\nThe\textent \tto\twhich \tsuch \tviral\tantisense \ttranscripts \tencode \tfunctional\t\nproteins \tremains \tlargely \tunknown.\tImmune\t Screening\t Identifies\t Novel\t T\tCell\tTargets\t Encoded\t by\tAntisense\t\nReading\t Frames\t of\tHIV-1\t\nChristoph \bT.\bBergera,b,\bAnuska \bLlanoc,\bJonathan \bM.\bCarlsond,\bZabrina \bL.\bBrummee,f,\bMark \bA.\bBrockmane,f,\bSamandhy\nCede\u00f1oc,\bP.\bRichard \bHarriganf,\bDaniel \bE.\bKaufmanna,g,\bDavid \bHeckermand,\bAndreas \bMeyerhansh,i,\bChristian \bBranderc,i,j,k\b\na\tRagon \tInstitute \tof\tMGH, \tMIT\tand\tHarvard, \tBoston, \tMassachusetts, \tUSA;\nb\tTranslational \tImmunology, \tDepartment \tof\tBiomedicine, \tUniversity \tHospital \tBasel, \tBasel,\n\t Switzerland;\nc\tIrsiCaixa \tAIDS \tResearch \tInstitute-HIVACAT, \tHospital \tGermans \tTrias \tI\tPujol, \tBadalona, \tSpain;\nd\tMicrosoft \tResearch, \tSeattle, \tWashington, \tUSA;\ne\tSimon \tFraser \tUniversity, \tBurnaby, \tBC,\tCanada;\nf\tBritish \tColumbia \tCentre \tfor\tExcellence \tin\tHIV/AIDS, \tVancouver, \tBC,\tCanada;\ng\tUniversity \tof\tMontreal \tHospital \tResearch \tCenter \t(CRCHUM), \tMontreal, \tQC,\tCanada;\nh\tInfection \tBiology \tGroup, \tDepartment \tof\tExperimental \tand\tHealth \tSciences, \tUniversitat \tPompeu\t\nFabra, \tBarcelona, \tSpain;\ni\tInstitucio \tCatalana \tde\tRecerca \ti\tEstudis \tAvancats \t(ICREA), \tBarcelona, \tSpain;\nj\tUniversity \tof\tVic\tand\tCentral \tUniversity \tof\tCatalonia, \tVic,\tCatalonia, \tSpain;\nk\tAutonomous \tUniversity \tof\tBarcelona, \tBarcelona, \tCatalonia, \tSpain\t\n18\t PUBLICATIONS \t DEPARTEMENT \tBIOMEDIZIN\nDBM \tFacts \t2|2015 \t Departement \tBiomedizinGamma-aminobutyric \tacid\t(GABA), \tthe\tmajor \tinhibitory \tneurotransmit -\nter\tin\tthe\tbrain, \tis\tfundamental \tto\tbrain \tfunction \tand\timplicated \tin\tthe\t\npathophysiology \tof\tseveral \tneuropsychiatric \tdisorders. \tGABA \tactivates\t\nG-protein-coupled \tGABA B\treceptors \tcomprising \tprincipal \tGABA B1\tand\t\nGABA B2\tsubunits \tas\twell\tas\tauxiliary \tKCTD8, \t12,\t12b\tand\t16\tsubunits. \tThe\t\nKCTD12 gene \thas\tbeen \tassociated \twith \tbipolar \tdisorder, \tmajor \tdepressive\ndisorder \tand\tschizophrenia. \tHere \twe\tcompare \tKctd12 \tnull\tmutant\t\n(Kctd12\u2212/\u2212)\tand\theterozygous \t(Kctd12+/\u2212)\twith \twild-type \t(WT) \tlittermate\t\nmice \tto\tdetermine \twhether \tlack\tof\tor\treduced \tKCTD12 \texpression \tleads\t\nto\tphenotypes \tthat, \textrapolating \tto\thuman, \tcould \tconstitute \tendophe -\nnotypes \tfor\tneuropsychiatric \tdisorders \twith \twhich \tKCTD12 \tis\tassociated.\tKctd12\u2212/\u2212\tmice \texhibited \tincreased \tfear\tlearning \tbut\tnot\tincreased \tmem -\nory\tof\ta\tdiscrete \tauditoryconditioned \tstimulus. \tKctd12+/\u2212\tmice \tshowed\t\nincreased \tactivity \tduring \tthe\tinactive \t(light) \tphase \tof\tthe\tcircadian \tcycle\t\nrelative \tto\tWT\tand\tKctd12\u2212/\u2212\tmice. \tElectrophysiological \trecordings \tfrom\t\nhippocampal \tslices, \ta\tregion \tof\thigh \tKctd12 \texpression, \trevealed \tan\t\nincreased \tintrinsic \texcitability \tof\tpyramidal \tneurons \tin\tKctd12\u2212/\u2212\tand\t\nKctd12+/\u2212\tmice. \tThis\tis\tthe\tfirst\tdirect \tevidence \tfor\tinvolvement \tof\tKCTD12\t\nin\tdetermining \tphenotypes \tof\temotionality, \tbehavioral \tactivity \tand\tneu-\nronal \texcitability. \tThis\tstudy \tprovides \tempirical \tsupport \tfor\tthe\tpolymor -\nphism \tand\texpression \tevidence \tthat\tKCTD12 \tconfers \trisk\tfor\tand\tis\tassoci -\nated \twith \tneuropsychiatric \tdisorders.\tAltered\t emotionality\t and\tneuronal\t excitability\t in\tmice\t lacking\t KCTD12,\nan\tauxiliary\t subunit\t of\tGABAB\treceptors\t associated\t with\t mood\t disorders\nF\bCathomas1,2,*,\bM\bStegen3,*,\bH\bSigrist1,\bL\bSchmid1,\bE\bSeifritz2,4,\bM\bGassmann3,\bB\bBettler3\band\bCR\bPryce1,4\b\n1\tPreclinical \tLaboratory \tfor\tTranslational \tResearch \tinto\tAffective \tDisorders \t(PLaTRAD),\nDepartment \tof\tPsychiatry, \tPsychotherapy \tand\tPsychosomatics, \tPsychiatric \tHospital, \tUniversity\t\nof\tZurich, \tZurich, \tSwitzerland;\n2\tDepartment \tof\tPsychiatry, \tPsychotherapy \tand\tPsychosomatics, \tPsychiatric \tHospital, \tUniversity\t\nof\tZurich, \tZurich, \tSwitzerland;\t\n3\tDepartment \tof\tBiomedicine, \tInstitute \tof\tPhysiology, \tUniversity \tof\tBasel, \tBasel, \tSwitzerland \tand\n4\tNeuroscience \tCenter, \tUniversity \tand\tETH\tZurich, \tZurich, \tSwitzerland.\t\n*\tThe\ttwo\tfirst\tauthors \tcontributed \tequally \tto\tthis\twork.\t\nTissue\bEngineering\b Part\bC,\bVol.\b21,\bNo.\b4,\b2015\b \b IF\b4.254Translational\bPsychiatry\b (2015)\b5,\be510;\bdoi:10.1038/tp.2015.8\b \b IF\b4.360\nEnzymatic \tisolation \tof\tchondrocytes \tfrom \ta\tcartilage \tbiopsy \tis\tthe\tfirst\t\nstep\tto\testablish \tin vitro \tmodels \tof\tchondrogenesis \tor\tto\tgenerate \tcell-\nbased \tgrafts \tfor\tcartilage \trepair. \tSuch \tprocess \tis\tbased \ton\tmanually \top-\nerated \tprocedures \tand\ttypically \tresults \tin\tyields \tlower \tthan \t20%\tof\tthe\t\ntotal \tavailable \tcells. \tIn\tthis\tstudy, \twe\thypothesized \tthat, \tas\tcompared \tto\t\nconventionally \tused \tprotocols, \tthe\tenzymatic \tdigestion \tof\thuman \tarticu -\nlar\tcartilage \tin\tthe\tpresence \tof\tascorbic \tacid\t2-phosphate \t(AscA2P) \tor\tof\t\nsodium \tchloride \t(NaCl), \tin\tcombination \twith \tthe\tuse\tof\ta\tperfusion \tbiore -\nactor \tsystem, \tleads \tto\ta\thigher \tand\tmore \treproducible \tyield \tof\tcell\tpopu -\nlations \twith \thigh \tproliferation \tand\tchondrogenic \tcapacity. \tThe\taddition\t\nof\tAscA2P \twithin \tthe\tenzymatic \tdigestion \tmedium \tdid\tnot\tsigni ficantly\t\nincrease \tthe\tcell\tyield, \tbut\tresulted \tin\ta\tsigni ficant\tdecrease \tof\tthe\tin-\ntradonor \tvariability \tin\tcell\tyield \t(\u221217.8% \t\u00b1\t10.7%, \tp\t=\t0.0247) \tand\tin\ta\tsigni ficant\tincrease \tof\tthe\tproliferation \trate\tof\tthe\tisolated \tchondrocytes\t\n(+\t19.0% \t\u00b1\t1.4%, \tp\t<\t0.05) \twith \trespect \tto\tthe\tcontrol \tgroup. \tThe\taddi-\ntion\tof\tNaCl \tduring \tcartilage \tdigestion \tdid\tnot\tmodulate \tcell\tyield. \tWhen\t\nthe\tcartilage \tdigestion \twas\tfurther \tperformed \tunder \tdirect \tperfusion\t\nflow,\tbene ficial\tsynergistic \teffects \twere \tachieved, \twith \tan\toverall \tincrease\t\nof\t34.7% \t\u00b1\t6.8% \t(p\t<\t0.001) \tin\tthe\tcell\tyield \tand\tan\taverage \tdecrease \tof\t\n57.8% \t\u00b1\t11.2% \t(\tp\t<\t0.01) \tin\tthe\tcoefficient \tof\tvariation \twith \trespect \tto\tthe\t\ncontrol \tgroup. \tImportantly, \tby\timplementing \tthis\tstrategy \tit\twas\tpossible\t\nto\tretrieve \tclonal \tsubpopulations \tmore \tefficiently \tcapable \tof\tundergoing\t\nchondrogenesis, \tboth \tin vitro \tand\tin vivo .\tOur\tfindings \tbear \trelevance \tfor\t\nthe\tpreparation \tof\thuman \tchondrocytes \tfor\tlaboratory \tinvestigations,\t\nand\tin\tthe\tperspective \tof\tefficient \tand\tstreamlined \tmanufacturing \tof\tcell/\ntissue \tgrafts \tfor\tarticular \tcartilage \trepair.\tAn\tImproved\t Cartilage\t Digestion\t Method\t for\tResearch\t and\tClinical\nApplications\t\nMatteo \bCentola, \bPhD1,\bBeatrice \bTonnarelli, \bPhD1,\bJeanine \bHendriks, \bPhD2,\bMirella \bvan\bden\bDoel, \bBS2,\bSandra \bFeliciano, \bBS1,\nAdam \bPapadimitropoulos, \bPhD1,3,\bElia\bPiccinini, \bPhD1,3,\bJeroen \bGeurts, \bPhD4,\bIvan\bMartin, \bPhD1,\band\bAndrea \bBarbero, \bPhD1\b\nDepartments \tof\n1\tSurgery \tand\tof\tBiomedicine, \tUniversity \tHospital \tBasel, \tUniversity \tof\tBasel, \tBasel, \tSwitzerland.\t\n2\tCellCoTec \tBV,\tBilthoven, \tThe\tNetherlands.\t\n3\tCellec \tBiotek \tAG,\tBasel, \tSwitzerland.\t\n4\tOrthopaedic \tDepartment, \tOsteoarthritis \tResearch \tCenter \tBasel, \tUniversity \tHospital \tBasel, \tBasel,\t\nSwitzerland.\t\nDEPARTMENT \tOF\tBIOMEDICINE\t PUBLICATIONS\t 19\nDBM \tFacts \t2|2015 \t Department \tof\tBiomedicineFollowing \tthe\tcoordinated \tefforts \tof\t five\testablished \tscienti fic\torgani -\nzations, \tthis\treport \tdescribes \tactivity \tin\tEurope \tfor\tthe\tyear\t2012 \tin\tthe\t\narea\tof\tcellular and engineered tissue therapies ,\texcluding \thematopoietic\t\nstem \tcell\t(HSC) \ttreatments \tfor\tthe\treconstitution \tof\thematopoiesis. \tThree\t\nhundred \tthirteen \tteams \tfrom \t33\tcountries \tresponded \tto\tthe\tcellular \tand\t\nengineered \ttissue \ttherapy \tsurvey: \t138\tteams \tfrom \t27\tcountries \tprovided\t\ndata\ton\t2157 \tpatients, \twhile \ta\tfurther \t175\tteams \treported \tno\tactivity. \tIn-\ndications \twere \tmusculoskeletal/rheumatological \tdisorders \t(36%; \t80%\tau-\ntologous), \tcardiovascular \tdisorders \t(25%; \t95% \tautologous), \thematology/\noncology, \tpredominantly \tprevention \tor\ttreatment \tof\tgraft \tversus \thost\t\ndisease \tand\tHSC\tgraft \tenhancement \t(19%; \t1%\tautologous), \tneurological\t\ndisorders \t(3%;\t99%\tautologous), \tgastrointestinal \tdisorders \t(1%;\t71%\tau-Tissue\bEngineering\b Part\bA,\bVol.\b21,\bNo.\b1\band\b2,\b2015\b \b IF\b4.254\ntologous), \tand\tother \tindications \t(16%; \t79%\tautologous). \tAutologous \tcells\t\nwere \tpredominantly \tused \tfor\tmusculoskeletal/ \trheumatological \t(42%)\t\nand\tcardiovascular \t(34%) \tdisorders, \twhereas \tallogeneic \tcells \twere \tmainly\t\nused \tfor\thematology/oncology \t(60%). \tThe\treported \tcell\ttypes \twere \tmes-\nenchymal \tstem/stromal \tcells \t(49%), \tHSC\t(28%), \tchondrocytes \t(11%),\t\ndermal \t fibroblasts \t(4%), \tkeratinocytes \t(1%), \tand\tothers \t(7%). \tIn\t51%\tof\t\nthe\tgrafts, \tcells \twere \tdelivered \tafter \tex\tvivo\texpansion, \twhereas \tcells\t\nwere \ttransduced \tor\tsorted \tin\t10%\tand\t16%, \trespectively, \tof\tthe\treported\t\ncases. \tCells \twere \tdelivered \tintra-organ \t(35%), \tintravenously \t(31%), \ton\ta\t\nmembrane \tor\tgel\t(15%), \tor\tusing \t3D\tscaffolds \t(19%). \tThe\tdata\tare\tcom -\npared \twith \tthose \tcollected \tsince \t2008 \tto\tidentify \ttrends \tin\tthe\tfield\tand\t\ndiscussed \tin\tthe\tlight \tof\trecent \tpublications \tand\tongoing \tclinical \tstudies.\t\nDepartments \tof\n1\tSurgery \tand\n2\tBiomedicine, \tUniversity \tHospital \tBasel, \tUniversity \tof\tBasel, \tBasel, \tSwitzerland.\t\n3\tEuropean \tGroup \tfor\tBlood \tand\tMarrow \tTransplantation, \tActivity \tSurvey \tOffice,\tUniversity\nHospital \tBasel, \tBasel, \tSwitzerland.\tThe\tSurvey\t on\tCellular\t and\tEngineered\t Tissue\t Therapies\t in\tEurope\t in\t2012\nIvan\bMartin, \bPhD1,2,\bHilary \bIreland, \bMSc1,2,\bHelen \bBaldomero, \bMSc3\band\bJakob \bPassweg, \bMD3\nFrontiers\bin\bCellular\bNeuroscience\b\b Feb.\b2015\b|\bVol.\b9\b|\bArt.\b16\b \b IF\b4.175\nMaintaining \tmitochondrial \tfunction \tis\tessential \tfor\tneuronal \tsurvival\t\nand\toffers \tprotection \tagainst \tneurodegeneration. \tUbiquitin-mediated,\t\nproteasome-dependent \tprotein \tdegradation \tin\tthe\tform \tof\touter \tmi-\ntochondrial \tmembrane \tassociated \tdegradation \t(OMMAD) \twas\tshown \tto\t\nplay\troles \tin\tmaintenance \tof\tmitochondria \ton\tthe\tlevel \tof\tproteostasis,\t\nbut\talso\tmitophagy \tand\tcell\tdeath. \tRecently, \tthe\tAAA-ATPase \t97/VCP/\nCdc48 \twas\trecognized \tas\tpart\tof\tOMMAD \tacting \tas\tretrotranslocase \tof\t\nubiquitinated \tmitochondrial \tproteins \tfor\tproteasomal \tdegradation.\t\nThus, \tp97\tlikely \tplays \ta\tmajor \trole\tin\tmitochondrial \tmaintenance. \tSup-\nport\tfor\tthis\tnotion \tcomes \tfrom \tmitochondrial \tdysfunction \tassociated\t\nwith \tamyotrophic \tlateral \tsclerosis \tand\thereditary \tinclusion \tbody \tmyopa -\nthy\tassociated \twith \tPaget \tdisease \tof\tbone \tand\tfrontotemporal \tdementia\t\n(IBMPFD) \tcaused \tby\tp97\tmutation. \tUsing \tSH-SY5Y \tcells \tstably \texpress -\ning\tp97\tor\tdominant-negative \tp97QQ\ttreated \twith \tmitochondrial \ttoxins\t\nrotenone, \t6-OHDA, \tor\tA\u03b2-peptide \tas\tmodel \tfor\tneuronal \tcells \tsuffering\tfrom \tmitochondrial \tdysfunction, \twe\tfound \tmitochondrial \tfragmenta -\ntion\tunder \tnormal \tand\tstress \tconditions \twas\tsigni ficantly \tincreased \tupon\t\ninactivation \tof\tp97.\tFurthermore, \tinactivation \tof\tp97\tresulted \tin\tloss\tof\t\nmitochondrial \tmembrane \tpotential \tand\tincreased \tproduction \tof\treactive\t\noxygen \tspecies \t(ROS). \tUnder \tadditional \tstress \tconditions, \tloss\tof\tmito -\nchondrial \tmembrane \tpotential \tand\tincreased \tROS\tproduction \twas\teven\t\nmore \tpronounced. \tLoss\tof\tmitochondrial \tfidelity \tupon \tinactivation \tof\tp97\t\nwas\tlikely \tdue\tto\tdisturbed \tmaintenance \tof\tmitochondrial \tproteostasis \tas\t\nthe\temployed \ttreatments \tneither \tinduced \tmitophagy \tnor\tcell\tdeath. \tThis\t\nwas\tsupported \tby\tthe\taccumulation \tof\toxidatively-damaged \tproteins \ton\t\nmitochondria \tin\tresponse \tto\tp97\tinactivation. \tDysfunction \tof\tp97\tunder\t\nnormal \tand\tstress \tconditions \tin\tneuron-like \tcells \tseverely \timpacts \tmito -\nchondrial \tfunction, \tthus \tsupporting \tfor\tthe\tfirst\ttime \ta\trole\tfor\tp97\tas\ta\t\nmajor \tcomponent \tof\tmitochondrial \tproteostasis.\tMitochondrial\t function\t in\tneuronal\t cells\t depends\t on\t\np97/VCP/Cdc48-mediated\t quality\t control\t\nLei\bFang1,\bCharles \bHemion1,\bAna\bC.\bPinho \bFerreira \bBento1,\bClaudia \bC.\bBippes1,\bJosef \bFlammer2\band\bAlbert \bNeutzner1,2\n1\tDepartment \tof\tBiomedicine, \tUniversity \tof\tBasel, \tBasel, \tSwitzerland\n2\tDepartment \tof\tOphthalmology, \tUniversity \tof\tBasel, \tBasel, \tSwitzerland\t\n20\t PUBLICATIONS \t DEPARTEMENT \tBIOMEDIZIN\nDBM \tFacts \t2|2015 \t Departement \tBiomedizinAbstract: \tEpithelial \tto\tmesenchymal \ttransition \t(EMT) \tis\ta\tprogramme\t\ndefined\tin\tepithelial \tcells \tand\trecognized \tas\tplaying \ta\tcritical \trole\tin\tcan-\ncer\tprogression. \tAlthough \tmelanoma \tis\tnot\ta\tcancer \tof\tepithelial \tcells,\t\nhallmarks \tof\tEMT\thave \tbeen \tdescribed \tto\tplay\ta\tcritical \trole\tin\tmelanoma\t\nprogression. \tHere, \twe\tdemonstrate \tthat\tlong-term \tTGF\u03b2\texposure \tcan\tin-\nduce \ta\tdedifferentiated \tEMT-like \tstate \tresembling \ta\tpreviously \tdescribed\t\ninvasive \tphenotype \t(EMT-like). \tTGF\u03b2-induced \tEMT-like \tis\tmarked \tby\tthe\t\ndownregulation \tof\tmelanocyte \tdifferentiation \tmarkers, \tsuch \tas\tMITF, \tand\tthe\tupregulation \tof\tmesenchymal \tmarkers, \tsuch \tas\tN-cadherin, \tand\tan\t\nincrease \tin\tmelanoma \tcell\tmigration \tand\tcell\tinvasion. \tPharmacological\t\ninterference \tshows \tthe\tdependency \tof\tTGF\u03b2-induced \tEMT-like \ton\tthe\tac-\ntivation \tof\tthe\tPDGF \tsignalling \tpathway \tand\tthe\tsubsequent \tactivation \tof\t\nPI3K \tin\thuman \tmelanoma \tcells. \tTogether, \tthe\tdata\tprovide \tnovel \tinsights\t\ninto\tthe\ttranscriptional \tplasticity \tof\tmelanoma \tcells \tthat\tmight \tcontribute\t\nto\ttumor \tprogression \tin\tpatients \tand\tpropose \tavenues \tto\ttherapeutic \tin-\nterventions.\tPI3K\t signalling\t is\trequired\t for\ta\tTGF\u03b2-induced\t epithelial\u2013\t mesenchymal-like\t\ntransition\t (EMT-like)\t in\thuman\t melanoma\t cells\t\nNatalie \bC.\bSchlegel1,\bAnina \bvon\bPlanta1,\bDaniel \bS.\bWidmer2,\bReinhard \bDummer2\band\bGerhard \bChristofori1\n1\tDepartment \tof\tBiomedicine, \tUniversity \tof\tBasel, \tBasel, \tSwitzerland;\n2\tDepartment \tof\tDermatology, \tUniversity \tHospital \tZ\u00fcrich, \tSwitzerland\t\nJournal\bof\bCellular\bPhysiology\b\b 230:\b1258\u20131269,\b2015\b \b IF\b3.874Experimental\bDermatology\b 2015,\b24,\b22\u201328\b \b IF\b4.115\nMacrophages \tare\tkey\tplayers \tin\thealing \tprocesses. \tHowever, \tlittle \tis\t\nknown \ton\ttheir \tcapacity \tto\tmodulate \tthe\tdifferentiation \tpotential \tof\t\nmesenchymal \tstem/stromal \tcells \t(MSC). \tHere \twe\tinvestigated \twhether\t\nmacrophages \t(Mf)\twith, \trespectively, \tpro-in flammatory \tand\ttissue-\nremodeling \ttraits \tdifferentially \tmodulate \tchondrogenesis \tof\tbone \tmar-\nrow\tderived-MSC \t(BM-MSC). \tWe\tdemonstrated \tthat\tcoculture \tin\tcollagen\t\nscaffolds \tof\tBM-MSC \twith \tMf\tderived \tfrom \tmonocytes \tpolarized \twith\t\nM-CSF \t(M-Mf), \tbut\tnot\twith \tGM-CSF \t(GM-Mf) \tresulted \tin\tsigni ficantly\t\nhigher \tglycosaminoglycan \t(GAG) \tcontent \tthan \twhat \twould \tbe\texpected\t\nfrom \tan\tequal \tnumber \tof\tBM-MSC \talone \t(defined\tas\tchondro-induction).\t\nMoreover, \ttype \tII\tcollagen \twas\texpressed \tat\tsigni ficantly \thigher \tlevels \tin\t\nBM-MSC/M-Mf \tas\tcompared \tto\tBM-MSC/GM-Mf \tconstructs, \twhile \ttype\t\nX\tcollagen \texpression \twas\tunaffected. \tIn\torder \tto\tunderstand \tthe\tpos-sible \tcellular \tmechanism \taccounting \tfor\tchondro-induction, \tdeveloping\t\nmonoculture \tand\tcoculture \ttissues \twere \tdigested \tand\tthe\tproperties \tof\t\nthe\tisolated \tBM-MSC \tanalysed. \tWe\tobserved \tthat\tas\tcompared \tto\tmono -\ncultures, \tin\tcoculture \twith \tM-Mf, \tBM-MSC \tdecreased \tless\tmarkedly \tin\t\nnumber \tand\texhibited \thigher \tclonogenic \tand\tchondrogenic \tcapacity.\t\nDespite \ttheir \tchondro-inductive \teffect \tin\tvitro, \tM-Mf \tdid\tnot\tmodulate\t\nthe\tcartilage \ttissue \tmaturation \tin\tsubcutaneous \tpockets \tof\tnude \tmice, \tas\t\nevidenced \tby\tsimilar \taccumulation \tof\ttype \tX\tcollagen \tand\tcalci fied\ttissue.\t\nOur\tresults \tdemonstrate \tthat\tcoculture \tof\tBM-MSC \twith \tM-Mf \tresults \tin\t\nsynergistic \tcartilage \ttissue \tformation \tin\tvitro. \tSuch \teffect \tseems \tto\tresult\t\nfrom \tthe\tsurvival \tof\tBM-MSC \twith \thigh \tchondrogenic \tcapacity. \tStudies \tin\t\nan\torthotopic \tin\tvivo\tmodel \tare\tnecessary \tto\tassess \tthe\tclinical \trelevance\t\nof\tour\tfindings \tin\tthe\tcontext \tof\tcartilage \trepair.Anti-Inflammatory/Tissue\t Repair\t Macrophages\t Enhance\t the\tCartilage-Forming\t\nCapacity\t of\tHuman\t Bone\t Marrow-Derived\t Mesenchymal\t Stromal\t Cells\t\nSergio \bB.\bSesia1,2,*,\bRalph \bDuhr1,*,\bCarolina \bMedeiros \bDa\bCunha1,\bAtanas \bTodorov1,\bStefan \bSchaeren1,\bElisabetta \bPadovan1,\nGiulio \bSpagnoli, \bIvan\bMartin1,\band\bAndrea \bBarbero1\n1\tDepartments \tof\tSurgery \tand\tof\tBiomedicine, \tUniversity \tHospital \tBasel, \tUniversity \tof\tBasel, \tBasel,\t\nSwitzerland\t\n2\tDepartment \tof\tPediatric \tSurgery, \tUniversity \tChildren\u2019s \tHospital \tof\tBasel \t(UKBB), \tBasel,\nSwitzerland\n*\tThese \tauthors \tcontributed \tequally \tto\tthis\twork\nDEPARTMENT \tOF\tBIOMEDICINE\t PUBLICATIONS\t 21\nDBM \tFacts \t2|2015 \t Department \tof\tBiomedicineAbstract\t\n3,4-Methylenedioxymethamphetamine \t(MDMA; \t\u201cecstasy\u201d)isa \tpopular\t\nrecreational \tdrug. \tThe\taim\tof\tthe\tpresent \tstudy \twas\tto\texplore \tthe\trole\tof\t\ndopamine \tin\tthe\tpsychotropic \teffects \tof\tMDMA \tusing \tbupropion \tto\tinhibit\t\nthe\tdopamine \tand\tnorepinephrine \ttransporters \tthrough \twhich \tMDMA \tre-\nleases \tdopamine \tand\tnorepinephrine. \tThe\tpharmacodynamic \tand\tphar -\nmacokinetic \tinteractions \tbetween \tbupropion \tand\tMDMA \tin\t16\thealthy\t\nsubjects \twere \tinvestigated \tusing \ta\tdouble-blind, \tplacebo-controlled,\t\ncrossover \tdesign. \tBupropion \treduced \tthe\tMDMA-induced \televations \tin\t\nplasma \tnorepinephrine \tconcentrations \tand\tthe\theart \trate\tresponse \tto\tThe\bJournal\bof\bPharmacology\band\bExperimental\bTherapeutics \b 353:102\u2013111,\bApril\b2015\b \b IF\b3.855\nMDMA. \tIn\tcontrast, \tbupropion \tincreased \tplasma \tMDMA \tconcentrations\t\nand\tprolonged \tits\tsubjective \teffects. \tConversely, \tMDMA \tincreased \tplasma\t\nbupropion \tconcentrations. \tThese \tresults \tindicate \ta\trole\tfor\tthe\ttransport -\ner-mediated \trelease \tof\tnorepinephrine \tin\tthe\tcardiostimulant \teffects \tof\t\nMDMA \tbut\tdo\tnot\tsupport \ta\tmodulatory \trole\tfor\tdopamine \tin\tthe\tmood\t\neffects \tof\tMDMA. \tThese \tresults \talso\tindicate \tthat\tthe\tuse\tof\tMDMA \tduring\t\ntherapy \twith \tbupropion \tmay\tresult \tin\thigher \tplasma \tconcentrations \tof\t\nboth \tMDMA \tand\tbupropion \tand\tenhanced \tmood \teffects \tbut\talso \tresult \tin\t\nlower \tcardiac \tstimulation.\t\nDivision \tof\tClinical \tPharmacology \tand\tToxicology, \tDepartment \tof\tBiomedicine \tand\tDepartment\t\nof\tClinical \tResearch, \tUniversity \tHospital \tBasel, \tBasel, \tSwitzerland \t(Y.S., \tA.R., \tA.S.,\tU.D., \tC.M.H.,\t\nM.E.L.); \tand\tBiomedicine \tService, \tUniversity \tHospital \tLausanne, \tLausanne, \tSwitzerland \t(E.G.)\n*\tThese \tauthors \tcontributed \tequally \tto\tthis\tworkInteractions\t between\t Bupropion\t and\t3,4-Methylenedioxymethamphetamine\t\nin\tHealthy\t Subjects\t\nYasmin \bSchmid*, \bAnna \bRickli*, \bAntonia \bSchaffner, \bUrs\bDuthaler, \bEric\bGrouzmann, \bC\u00e9dric \bM.\bHysek, \band\bMatthias \bE.\bLiechti\b\nGlycobiology\b\b 2015,\bvol.\b25,\bno.\b4,\b351\u2013356\b IF\b3.747\nAbstract\bGlucosylceramide \tsynthase \t(GCS) \tcatalyzes \tthe\t first\tcommitted \tstep\tin\t\nthe\tbiosynthesis \tof\tglucosylceramide \t(GlcCer)-related \tglycosphingolip -\nids\t(GSLs). \tAlthough \tinhibitors \tof\tGCS, \tPPMP \tand\tPDMP \thave \tbeen \twidely\t\nused \tto\telucidate \ttheir \tbiological \tfunction \tand\trelevance, \tour\tcompre -\nhensive \tliterature \treview \trevealed \tthat\tthe\tavailable \tdata\tare\tambiguous.\t\nWe\ttherefore \tinvestigated \twhether \tand\tto\twhat \textent \tGCS\tinhibitors\t\naffect \tthe\texpression \tof\tlactosylceramide \t(LacCer), \tneolacto \t(nLc4 \tand\t\nP\n1),\tganglio \t(GM1 \tand\tGD3) \tand\tglobo \t(Gb3 \tand\tSSEA3) \tseries \tGSLs \tin\ta\t\npanel \tof\thuman \tcancer \tcell\tlines \tusing \tflow\tcytometry, \ta\tcommonly \tap-\nplied \tmethod \tinvestigating \tcell-surface \tGSLs \tafter \tGCS\tinhibition. \tTheir\tcell-surface \tGSL\texpression \tconsiderably \tvaried \tamong \tcell\tlines \tand\t\nmore \timportantly, \tsublethal \tconcentrations \t(IC 10)\tof\tboth \tinhibitors \tpref-\nerentially \tand\tsigni ficantly \treduced \tthe\texpression \tof\tGb3\tin\tthe\tcancer\t\ncell\tlines \tIGROV1, \tBG1, \tHT29 \tand\tT47D, \twhereas \tSSEA3 \twas\tonly\treduced\t\nin\tBG1. \tUnexpectedly, \tthe\tneolacto \tand\tganglio \tseries \twas\tnot\taffected.\t\nLacCer, \tthe\tprecursor \tof\tall\tGlcCer-related \tGSL,\twas\tsigni ficantly \treduced\t\nonly\tin\tBG1\tcells \ttreated \twith \tPPMP. \tFuture \tresearch \tquestions \taddress -\ning\tparticular \tGSLs \trequire \tcareful \tconsideration; \tour\tresults \tindicate \tthat\t\nthe\textent \tto\twhich \tthere \tis\ta\tdecrease \tin\tthe\texpression \tof\tone\tor\tmore\t\nparticular \tGSLs \tis\tdependent \ton\tthe\tcell\tline\tunder \tinvestigation, \tthe\ttype\t\nof\tGCS\tinhibitor \tand\texposure \tduration.Glucosylceramide\t synthase\t inhibitors\t differentially\t affect\t expression\t of\nglycosphingolipids\t\nShahidul \bAlam, \bAndr\u00e9 \bFedier, \bReto \bS\bKohler, \band\bFrancis \bJacob\nGynecological \tResearch \tGroup, \tDepartment \tof\tBiomedicine, \tUniversity \tHospital \tBasel, \tUniversity\t\nof\tBasel, \tHebelstrasse \t20,\tBasel \t4031, \tSwitzerland\t\n22\t PUBLICATIONS \t DEPARTEMENT \tBIOMEDIZIN\nDBM \tFacts \t2|2015 \t Departement \tBiomedizinAbstract\nObjectives: \tAntibody\u2013cytokine \tfusion \tproteins \t(immunocytokines) \trep-\nresent \ta\tnovel \tclass \tof\tarmed \tantibodies \tin\toncology. \tIn\tparticular, \tIL2-\tand\t\nTNF-based \timmunocytokines \ttargeting \tthe\tEDB\tdomain \tof\tfibronectin\t\nand\tthe\tA1\tdomain \tof\ttenascin-C \thave \tdemonstrated \tpromising \tanti-\ntumor \tactivity \tand\tare\tcurrently \tinvestigated \tin\tPhase \tI\tand\tPhase \tII\tclini-\ncal\ttrials. \tTo\tadvance \tthe\tdevelopment \tof\timmunocytokines \tfor\tNSCLC,\t\nwe\there \treport \ton\tthe\ttherapeutic \tefficacy \tof\tF8-IL2, \tan\timmunocytokine\t\ndirected \tagainst \tthe\talternatively \tspliced \tEDA\tdomain \tof\tfibronectin \tin\ta\t\nfully \timmunocompetent, \torthotopic \tmodel \tof\tNSCLC, \tand\tthe\tcharacter -\nization \tof\tthe\ttarget \tantigen \texpression \tin\thuman \tNSCLC \tspecimens.\t\nMaterials \band\bmethods: \tWe\tevaluated \tthe\ttherapeutic \tefficacy \tof\tthe\t\nF8-IL2 \timmunocytokine \tutilizing \ta\tK-ras \tmutant, \tp53\tdeficient \tmetastatic\t\nmouse \tmodel \tof\tNSCLC \tderived \tfrom \tthe\tlatest \tgeneration \tof\tgenetically\t\nengineered \tand\tconditional \ttumor \tmodels. \tIn\tparallel, \twe\tassessed \tthe\t\npresence \tof\tthe\tEDA\tdomain \tof\tfibronectin \tby\timmunofluorescence \tin\t\nlung \tbiopsies \tobtained \tfrom \tpatients \twith \tNSCLC.\t\nResults: \tThe\tEDA\tdomain \tof\tfibronectin \twas\tbroadly \texpressed \tin\tlung\t\nmetastases \tobtained \tfrom \tour\tmodel. \tTreatment \twith \tF8-IL2 \tinduced\tsubstantial \tlocal \tchanges \twithin \timmune \teffector \tcell\tpopulations \tand\t\ndemonstrated \tpromising \ttherapeutic \tefficacy \tas\tmonotherapy. \tThe\ttar-\nget\tof\tF8-IL2, \tthe\tEDA\tdomain \tof\tfibronectin, \twas\tpresent \tin\tall\thuman\t\nlung \tadenocarcinoma \tspecimens \ttested.\t\nConclusion: \tBoth \tthe\ttherapeutic \tefficacy \tin\ta\tmetastatic \tmouse \tmodel\t\nof\tNSCLC \tand\tthe\textensive \tpresence \tof\tthe\tEDA\tdomain \tof\tfibronectin\t\nin\thuman \tNSCLC \tbiopsies \tsupport \tthe\trational \tdevelopment \tof\ttherapies\t\nbased \ton\tthe\tF8-IL2 \timmunocytokine \tfor\tthe\ttreatment \tof\tNSCLC.\tTherapeutic\t efficacy\t of\tthe\tF8-IL2\t immunocytokine\t in\ta\tmetastatic\t mouse\t\nmodel\t of\tlung\t adenocarcinoma\t\nS\u00e9bastien \bWieckowskia,\bTeresa \bHemmerleb,c,\bSpasenja \bSavic \bPrinced,\bB\u00e9atrice \bDolder \bSchliengera,\bSven \bHillingere,\bDario \bNerib,c,\b\nAlfred \bZippeliusa,f\b\na\tCancer \tImmunology \tand\tBiology, \tDepartment \tof\tBiomedicine, \tUniversity \tHospital \tBasel,\nUniversity \tof\tBasel, \tHebelstrasse \t20,\tCH-4031 \tBasel, \tSwitzerland\t\nb\tDepartment \tof\tChemistry \tand\tApplied \tBiosciences, \tETH\tZ\u00fcrich, \tWolfgang-Pauli-Strasse \t10,\nCH-8093 \tZ\u00fcrich, \tSwitzerland\t\nc\tPhilochem \tAG,\tLibernstrasse \t3,\tCH-8093 \tOtelfingen, \tSwitzerland\t\nd\tInstitute \tof\tPathology, \tUniversity \tHospital \tBasel, \tSch\u00f6nebeinstrasse \t40,\tCH-4003 \tBasel,\nSwitzerland\t\ne\tDepartment \tof\tThoracic \tSurgery, \tUniversity \tHospital \tZ\u00fcrich, \tSchmelzbergstrasse \t12,\nCH-8091 \tZ\u00fcrich, \tSwitzerland\t\nf\tMedical \tOncology, \tUniversity \tHospital \tBasel, \tPetersgraben \t4,\tCH-4031 \tBasel, \tSwitzerland\nAnal\bBioanal\bChem\b (2015)\b407:1577\u20131584\b \b IF\b3.578Lung\bCancer\b 88\b(2015)\b9\u201315\b \b IF\b3.737\nAbstract \tLysergic \tacid\tdiethylamide \t(LSD) \tis\ta\twidely \tused \trecreational\t\ndrug. \tThe\taim\tof\tthe\tpresent \tstudy \tis\tto\tdevelop \ta\tquantitative \tturboflow\t\nLC-MS/MS \tmethod \tthat\tcan\tbe\tused \tfor\trapid \tquantification \tof\tLSD\tand\t\nits\tmain \tmetabolite \t2-oxo-3-hydroxy \tLSD\t(O-H-LSD) \tin\tserum \tand\turine \tin\t\nemergency \ttoxicological \tcases \twithout \ttime-consuming \textraction \tsteps.\t\nThe\tmethod \twas\tdeveloped \ton\tan\tion-trap \tLC-MS/MS \tinstrument \tcoupled\t\nto\ta\tturbulent-flow \textraction \tsystem. \tThe\tvalidation \tdata\tshowed \tno\t\nsignificant \tmatrix \teffects \tand\tno\tion\tsuppression \thas\tbeen \tobserved \tin\t\nserum \tand\turine. \tMean \tintraday \taccuracy \tand\tprecision \tfor\tLSD\twere \t101\t\nand\t6.84 \t%,\tin\turine \tsamples \tand\t97.40 \tand\t5.89 \t%\tin\tserum, \trespectively.\t\nFor\tO-H-LSD, \tthe\trespective \tvalues \twere \t97.50 \tand\t4.99 \t%\tin\turine \tand\t\n107\tand\t4.70 \t%\tin\tserum. \tMean \tinterday \taccuracy \tand\tprecision \tfor\tLSD\t\nwere \t100\tand\t8.26 \t%\tin\turine \tand\t101\tand\t6.56 \t%\tin\tserum, \trespectively.\tFor\tO-H-LSD, \tthe\trespective \tvalues \twere \t101\tand\t8.11\t%\tin\turine \tand\t99.8\t\nand\t8.35 \t%\tin\tserum, \trespectively. \tThe\tlower \tlimit \tof\tquantification \tfor\t\nLSD\twas\tdetermined \tto\tbe\t0.1\tng/ml. \tLSD\tconcentrations \tin\tserum \twere\t\nexpected \tto\tbe\tup\tto\t8\tng/ml. \t2-Oxo-3-hydroxy \tLSD\tconcentrations \tin\t\nurine \tup\tto\t250\tng/ml. \tThe\tnew\tmethod \twas\taccurate \tand\tprecise \tin\tthe\t\nrange \tof\texpected \tserum \tand\turine \tconcentrations \tin\tpatients \twith \ta\tsus-\npected \tLSD\tintoxication. \tUntil \tnow, \tthe\tmethod \thas\tbeen \tapplied \tin\tfive\t\ncases \twith \tsuspected \tLSD\tintoxication \twhere \tthe\tintake \tof\tthe\tdrug \thas\t\nbeen \tverified \tfour\ttimes \twith \tLSD\tconcentrations \tin\tserum \tin\tthe\trange\t\nof\t1.80\u201314.70 \tng/ml \tand\tonce \twith \ta\tLSD\tconcentration \tof\t1.25\tng/ml\t\nin\turine. \tIn\tserum \tof\ttwo\tpatients, \tthe\tO-H-LSD \tconcentration \twas\tde-\ntermined \tto\tbe\t0.99 \tand\t0.45 \tng/ml. \tIn\tthe\turine \tof\ta\tthird \tpatient, \tthe\t\nO-H-LSD \tconcentration \twas\t9.70 \tng/ml.Development\t and\tvalidation\t of\ta\trapid\t turboflow\t LC-MS/MS\t method\t for\tthe\t\nquantification\t of\tLSD\tand\t2-oxo-3-hydroxy\t LSD\tin\tserum\t and\turine\t samples\t\nof\temergency\t toxicological\t cases\t\nPatrick \bC.\bDolder1,2,\bMatthias \bE.\bLiechti2,\bKatharina \bM.\bRentsch1\n1\tLaboratory \tMedicine, \tUniversity \tHospital, \tPetersgraben \t4,\t4031 \tBasel, \tSwitzerland\t\n2\tDivision \tof\tClinical \tPharmacology \tand\tToxicology, \tDepartment \tof\tBiomedicine \tand\tDepartment\t\nof\tClinical \tResearch, \tUniversity \tHospital \tand\tUniversity \tof\tBasel, \tHebelstrasse \t20,\t4031 \tBasel,\t\nSwitzerland\nDEPARTMENT \tOF\tBIOMEDICINE\t PUBLICATIONS\t 23\nDBM \tFacts \t2|2015 \t Department \tof\tBiomedicineAbstract\t\nThe\tkinase \tAkt\tis\ta\tkey\tdownstream \tmediator \tof\tthe\tphosphoinositide-3-\nkinase \tsignaling \tpathway \tand\tparticipates \tin\ta\tvariety \tof\tcellular \tprocess -\nes.\tAkt\tcomprises \tthree \tisoforms \teach \tencoded \tby\ta\tseparate \tgene. \tThere\t\nis\tevidence \tto\tindicate \tthat\tAkt\tis\tinvolved \tin\tthe\tsurvival \tand\tprotection\t\nof\tauditory \thair\tcells \tin\tvitro. \tHowever, \tlittle \tis\tknown \tabout \tthe\tphysi -\nological \trole\tof\tAkt\tin\tthe\tinner \tear\u2014especially \tin\tthe\tintact \tanimal. \tTo\t\nelucidate \tthis\tissue, \twe\tfirst\tanalyzed \tthe\tmRNA \texpression \tof\tthe\tthree\t\nAkt\tisoforms \tin\tthe\tinner \tear\tof\tC57/ \tBL6\tmice \tby\treal-time \tPCR. \tNext,\t\nwe\ttested \tthe\tsusceptibility \tto\tgentamicin-induced \tauditory \thair\tcell\tloss\t\nin\tisoform-specific \tAkt\tknockout \tmice \tcompared \tto\twild-types \t(C57/BL6)\t\nin\tvitro. \tTo\tanalyze \tthe\teffect \tof\tgene \tdeletion \tin\tvivo, \thearing \tand\tco-\nchlear \tmicroanatomy \twere \tevaluated \tin\tAkt\tisoform \tknockout \tanimals.\t\nIn\tthis\tstudy, \twe\tfound \tthat\tall\tthree \tAkt\tisoforms \tare\texpressed \tin\tthe\t\ncochlea. \tOur\tresults \tfurther \tindicate \tthat\tAkt2 \tand\tAkt3 \tenhance \thair\tcell\t\nresistance \tto\tototoxicity, \twhile \tAkt1 \tdoes \tnot.\tFinally, \twe\tdetermined \tthat\t\nuntreated \tAkt1 \tand\tAkt2/Akt3 \tdouble \tknockout \tmice \tdisplay \tsignificant\t\nhearing \tloss, \tindicating \ta\trole\tfor\tthese \tisoforms \tin\tnormal \thearing. \tTaken\tPLOS\bONE\b DOI:10.1371/journ.pone.0121599\bMarch\b26,\b2015 \bIF\b3.534\ntogether, \tour\tresults \tindicate \tthat\teach \tof\tthe\tAkt\tisoforms \tplays \ta\tdistinct\t\nrole\tin\tthe\tmammalian \tinner \tear.\t\n1\tDepartment \tof\tBiomedicine, \tUniversity \tHospital \tBasel, \tHebelstrasse \t20,\t4031 \tBasel,\nSwitzerland,\n2\tClinic \tfor\tOtolaryngology, \tHead \tand\tNeck \tSurgery, \tUniversity \tHospital \tBasel, \tPetersgraben \t4,\t\n4031 \tBasel, \tSwitzerland,\n3\tInner \tEar\tResearch, \tClinic \tfor\tOtolaryngology, \tHead \tand\tNeck \tSurgery, \tUniversity \tHospital\t\nZ\u00fcrich, \tFrauenklinikstrasse \t24,\tNORD \t2,\t8091 \tZ\u00fcrich, \tSwitzerland,\n4\tDepartments \tof\tSurgery/ \tOtolaryngology, \tUCSD \tSchool \tof\tMedicine, \t9500 \tGilman \tDrive\t\nMC0666, \tLa\tJolla, \tCA\t92093, \tUnited \tStates \tof\tAmerica,\n5\tDepartment \tof\tNeurosciences, \tUCSD \tSchool \tof\tMedicine, \t9500 \tGilman \tDrive \tMC0666, \tLa\tJolla,\t\nCA\t92093, \tUnited \tStates \tof\tAmerica,\n6\tSan\tDiego \tVA\tMedical \tCenter, \t3350 \tLa\tJolla \tVillage \tDrive, \tSan\tDiego, \tCA\t92161, \tUnited \tStates \tof\t\nAmerica,\n7\tMechanisms \tof\tCancer \tProgram, \tFriedrich \tMiescher \tInstitute \tfor\tBiomedical \tResearch, \tBasel,\t\nSwitzerland\t\nPLOS\bONE\b DOI:10.1371/journ.pone.0124870\bApril\b22,\b2015 \bIF\b3.534\nAbstract\bBackground\tMedulloblastomas \tare\tmalignant \tchildhood \tbrain \ttumors \tthat\tarise \tdue\t\nto\tthe\taberrant \tactivity \tof\tdevelopmental \tpathways \tduring \tpostnatal\t\ncerebellar \tdevelopment \tand\tin\tadult \thumans. \tTranscriptome \tanalysis\t\nhas\tidentified \tfour\tmajor \tmedulloblastoma \tsubgroups. \tOne\tof\tthem, \tthe\t\nSonic \thedgehog \t(SHH) \tsubgroup, \tis\tcaused \tby\taberrant \tHedgehog \tsignal\t\ntransduction \tdue\tto\tmutations \tin\tthe\tPatched1 (PTCH1) \treceptor \tor\tdown -\nstream \teffectors. \tMice \tcarrying \ta\tPatched-1 \tnull\tallele \t(Ptch1\n\u2206/+)\tare\ta\tgood\t\nmodel \tto\tstudy \tthe\talterations \tunderlying \tmedulloblastoma \tdevelop -\nment \tas\ta\tconsequence \tof\taberrant \tHedgehog \tpathway \tactivity.\tResults\bTranscriptome \tanalysis \tof\thuman \tmedulloblastomas \tshows \tthat\tSER-\nPINE2 ,\talso\tcalled \tProtease \tNexin-1 (PN-1) \tis\toverexpressed \tin\tmost \tmedul -\nloblastomas, \tin\tparticular \tin\tthe\tSHH\tand\tWNT \tsubgroups. \tAs\tsiRNA-me -\ndiated \tlowering \tof\tSERPINE2/PN-1 \tin\thuman \tmedulloblastoma \tDAOY \tcells\t\nreduces \tcell\tproliferation, \twe\tanalyzed \tits\tpotential \tinvolvement \tin\tme-\ndulloblastoma \tdevelopment \tusing \tthe\tPtch1\n\u2206/+\tmouse \tmodel. \tIn\tPtch1\u2206/+\t\nmice, \tmedulloblastomas \tarise \tas\ta\tconsequence \tof\taberrant \tHedgehog\t\npathway \tactivity.Serpine2/PN-1\t Is\tRequired\t for\tProliferative\t Expansion\t of\tPre-Neoplastic\t\nLesions\t and\tMalignant\t Progression\t to\tMedulloblastoma\t\nCatherine \bVaillant1,\bPaola \bValdivieso1,*,\bSandro \bNuciforo1,*,\bMarcel \bKool2,\bAlexandra \bSchwarzentruber-Schauerte1,\nH\u00e9l\u00e8ne \bM\u00e9reau1,\bErik\bCabuy3,\bJohannes \bA.\bLobrinus4,\bStefan \bPfister2,\bAim\u00e9e \bZuniga1,\bStephan \bFrank5,\bRolf\bZeller1All\tAkt\tIsoforms\t (Akt1,\t Akt2,\t Akt3)\t Are\tInvolved\t in\tNormal\t Hearing,\t but\tOnly\t\nAkt2\t and\tAkt3\t Are\tInvolved\t in\tAuditory\t Hair\t Cell\tSurvival\t in\tthe\tMammalian\t\nInner\t Ear\nYves \bBrand1,2,\bSoledad \bLevano1,2,\bVesna \bRadojevic1,2,\bArianne \bMonge \bNaldi3,\bCristian \bSetz1,2,\bAllen \bF.\bRyan4,5,6,\bKwang \bPak4,6,\nBrian \bA.\bHemmings7,\bDaniel \bBodmer1,2\n1\tDevelopmental \tGenetics, \tDepartment \tof\tBiomedicine, \tUniversity \tof\tBasel, \tBasel, \tSwitzerland,\n2\tDivision \tof\tPediatric \tNeuro-Oncology, \tGerman \tCancer \tResearch \tCenter \tDKFZ, \tHeidelberg,\t\nGermany,\n3\tSingle \tCell\tGenomics, \tFriedrich \tMiescher \tInstitute, \tBasel, \tSwitzerland,\n4\tNeuropathology \tUnit, \tDepartment \tof\tClinical \tPathology, \tUniversity \tHospital \tGeneva, \tGeneva,\t\nSwitzerland,\n5\tDivision \tof\tNeuropathology, \tInstitute \tof\tPathology, \tUniversity \tof\tBasel, \tBasel, \tSwitzerland\t\n*\tThese \tauthors \tcontributed \tequally \tto\tthis\twork.\n24\t PUBLICATIONS \t DEPARTEMENT \tBIOMEDIZIN\nDBM \tFacts \t2|2015 \t Departement \tBiomedizinAbstract\t\nLiver \tsinusoidal \tendothelial \tcells \t(LSECs) \tare\tspecialized \tscavenger \tcells\t\nthat\tmediate \thigh-capacity \tclearance \tof\tsoluble \twaste \tmacromolecules\t\nand\tcolloid \tmaterial, \tincluding \tblood-borne \tadenovirus. \tTo\texplore \tif\t\nLSECs \tfunction \tas\ta\tsink\tfor\tother \tviruses \tin\tblood, \twe\tstudied \tthe\tfate\tof\t\nvirus-like \tparticles \t(VLPs) \tof\ttwo\tubiquitous \thuman \tDNA \tviruses, \tBK\tand\t\nJC\tpolyomavirus, \tin\tmice. \tLike\tcomplete \tvirions, \tVLPs \tspecifically \tbind \tto\t\nreceptors \tand\tenter \tcells, \tbut\tunlike \tcomplete \tvirions, \tthey \tcannot \trepli -\ncate. \t125I-labeled \tVLPs \twere \tused \tto\tassess \tblood \tdecay, \torgan-, \tand\thepa -\ntocellular \tdistribution \tof\tligand, \tand\tnon-labeled \tVLPs \tto\texamine \tcellular\t\nuptake \tby\timmunohisto-and \t-cytochemistry. \tBK-and \tJC-VLPs \trapidly \tdis-\ntributed \tto\tliver, \twith \tlesser \tuptake \tin\tkidney \tand\tspleen. \tLiver \tuptake \twas\t\npredominantly \tin\tLSECs. \tBlood \thalf-life \t(~1\tmin), \tand\ttissue \tdistribution\t\nof\tJC-VLPs \tand\ttwo\tJC-VLP-mutants \t(L55F \tand\tS269F) \tthat\tlack\tsialic \tacid\t\nbinding \taffinity, \twere \tsimilar, \tindicating \tinvolvement \tof\tnon-sialic \tacid\t\nreceptors \tin\tcellular \tuptake. \tLiver \tuptake \twas\tnot\tmediated \tby\tscaven -\nger\treceptors. \tIn\tspleen, \tthe\tVLPs \tlocalized \tto\tthe\tred\tpulp \tmarginal \tzone\t\nreticuloendothelium, \tand\tin\tkidney \tto\tthe\tendothelial \tlining \tof\tvasa\trecta\t\nsegments, \tand\tthe\ttransitional \tepithelium \tof\trenal \tpelvis. \tMost \tVLP-pos -itive\tvessels \tin\trenal \tmedulla \tdid\tnot\texpress \tPV-1/Meca \t32,\tsuggesting\t\nlocation \tto\tthe\tnon-fenestrated \tpart\tof\tvasa\trecta. \tThe\tendothelial \tcells\t\nof\tthese \tvessels \talso\tefficiently \tendocytosed \ta\tscavenger \treceptor \tligand,\t\nformaldehyde-denatured \talbumin, \tsuggesting \thigh \tendocytic \tactivity\t\ncompared \tto\tother \trenal \tendothelia. \tWe\tconclude \tthat\tLSECs \tvery \teffec -\ntively \tcleared \ta\tlarge \tfraction \tof\tblood-borne \tBK-and \tJC-VLPs, \tindicating\t\na\tcentral \trole\tof\tthese \tcells \tin\tearly \tremoval \tof\tpolyomavirus \tfrom \tthe\tcir-\nculation. \tIn\taddition, \twe\treport \tthe\tnovel \tfinding \tthat\ta\tsubpopulation \tof\t\nendothelial \tcells \tin\tkidney, \tthe\tmain \torgan \tof\tpolyomavirus \tpersistence,\t\nshowed \tselective \tand\trapid \tuptake \tof\tVLPs, \tsuggesting \ta\trole\tin\tviremic\t\norgan \ttropism.Efficient\t Uptake\t of\tBlood-Borne\t BK\tand\tJC\tPolyomavirus-Like\t Particles\nin\tEndothelial\t Cells\t of\tLiver\t Sinusoids\t and\tRenal\t Vasa\t Recta\t\nJaione \bSimon-Santamaria1,\bChristine \bHanssen \bRinaldo2,3,\bPiotr \bKardas4,\bRuomei \bLi1,\bIvana \bMalovic1,\bKjetil \bElvevold1,\nPeter \bMcCourt1,\bB\u00e5rd \bSmedsr\u00f8d1,\bHans \bH.\bHirsch4,5,*,\bKaren \bKristine \bS\u00f8rensen1,*\n1\tDepartment \tof\tMedical \tBiology, \tUiT\t\u2013\tThe\tArctic \tUniversity \tof\tNorway, \tTroms\u00f8, \tNorway,\n2\tDepartment \tof\tMicrobiology \tand\tInfection \tControl, \tUniversity \tHospital \tof\tNorth \tNorway,\t\nTroms\u00f8, \tNorway,\n3\tDepartment \tof\tClinical \tMedicine, \tUiT\t-\tThe\tArctic \tUniversity \tof\tNorway, \tTroms\u00f8, \tNorway,\n4\tDepartment \tof\tBiomedicine, \tUniversity \tof\tBasel, \tBasel, \tSwitzerland,\n5\tDivisions \tof\tInfectious \tDiseases \tand\tHospital \tEpidemiology, \tUniversity \tHospital \tof\tBasel, \tBasel,\t\nSwitzerland\n*\tThese \tauthors \tcontributed \tequally \tto\tthis\twork.\nJournal\bof\bClinical\bVirology\b 62\b(2015)\b72\u201374\b \b IF\b3.466PLOS\bONE\b Nov.\b2014,\bVol.\b9,\bIssue\b11,\be111762\b IF\b3.534\nAbstractPatients \tundergoing \thaematopoietic \tstem \tcell\ttransplantation \t(HSCT) \tare\t\nat\thigh \trisk\tof\tsevere \tgastrointestinal \tbleeding \tcaused \tby\tinfections, \tgraft\t\nversus \thost \tdisease, \tand\tdisturbances \tin\thaemostasis. \tBK\tpolyomavirus\t\n(BKPyV) \tis\tknown \tto\tcause \themorrhagic \tcystitis, \tbut\tthere \tis\talso\tevidence\t\nof\tBKV\tshedding \tin\tstool \tand\tits\tassociation \twith \tgastrointestinal \tdisease.\t\nWe\treport \tputative \tassociation \tof\tBKPyV \treplication \twith \thigh \tplasma \tviral\t\nloads \tin\ta\tpediatric \tHSCT \tpatient \tdeveloping \themorrhagic \tcystitis \tand\tse-\nvere\tgastrointestinal \tbleeding \tnecessitating \tintensive \tcare. \tThe\tobserva -\ntion\twas\tbased \ton\tchart \treview \tand\tanalysis \tof\tBKPyV \tDNA \tloads \tin\tplasma\tand\turine \tas\twell\tas\tretrospective \tBKPyV-specific \tIgM\tand\tIgG\tmeasure -\nments \tin\tweekly \tsamples \tuntil \tthree \tmonths \tpost-transplant. \tThe\tgastro -\nintestinal \tbleeding \twas\tobserved \tafter \ta\t>100-fold \tincrease \tin\tthe\tplasma\t\nBKPyV \tloads \tand\tthe\tstart \tof\themorrhagic \tcystitis. \tThe\tBKPyV-specific\t\nantibody \tresponse \tindicated \tpast\tinfection \tprior \tto\ttransplantion, \tbut\t\nincreasing \tIgG\ttiters \twere \tseen \tfollowing \tBKPyV \treplication. \tThe\tgastro -\nintestinal \tbiopsies \twere \ttaken \tat\ta\tlate\tstage \tof\tthe\tepisode \tand\twere \tno\t\nlonger \tinformative \tof\tBK\tpolyomavirus \tinvolvement. \tIn\tconclusion, \tgas-\ntrointestinal \tcomplications \twith \tbleeding \tare\ta\tsignificant \tproblem \tafter\t\nallogeneic \tHSCT \tto\twhich \tviral\tinfections \tincluding \tBKPyV \tmay\tcontribute.Diffuse\t gastrointestinal\t bleeding\t and\tBK\tpolyomavirus\t replication\t in\ta\npediatric\t allogeneic\t haematopoietic\t stem\t cell\ttransplant\t patient\nM.\bKoskenvuoa,\bI.\bLautenschlagerb,\bP.\bKardasc,\bE.\bAuvinenb,\bL.\bMannonenb,\bP.\bHuttunena,\bM.\bTaskinena,\bK.\bVettenrantaa,\nH.H.\bHirschc,d\na\tDivision \tof\tHematology-Oncology \tand\tStem \tCell\tTransplantation, \tChildren\u2019s \tHospital, \tUniversity\t\nof\tHelsinki, \tFinland\nb\tDepartment \tof\tVirology, \tHelsinki \tUniversity \tHospital \t(HUSLAB) \tand\tUniversity \tof\tHelsinki,\nHelsinki, \tFinland\nc\tTransplantation \t&\tClinical \tVirology, \tDepartment \tBiomedicine, \tUniversity \tof\tBasel, \tBasel,\nSwitzerland\nd\tInfectious \tDiseases \t&Hospital \tEpidemiology, \tUniversity \tHospital \tBasel, \tBasel, \tSwitzerland\t\nDEPARTMENT \tOF\tBIOMEDICINE\t PUBLICATIONS\t 25\nDBM \tFacts \t2|2015 \t Department \tof\tBiomedicineAbstract\t\nBackground: \tIdiopathic \tpulmonary \tfibrosis \t(IPF) \tis\ta\tprogressive \tlung\t\ndisease \twith \tpoor \tprognosis. \tThe\tkinase \tinhibitor \tnintedanib \tspecific \tfor\t\nvascular \tendothelial \tgrowth \tfactor \treceptor \t(VEGFR), \tplatelet-derived\t\ngrowth \tfactor \treceptor \t(PDGFR) \tand\tfibroblast \tgrowth \tfactor \treceptor\t\n(FGFR) \tsignificantly \treduced \tthe\trate\tof\tdecline \tof\tforced \tvital\tcapacity\t\nversus \tplacebo.\t\nAim: \tTo\tdetermine \tthe\tin\tvitro \teffect \tof\tnintedanib \ton\tprimary \thuman\t\nlung \tfibroblasts. \tMethods: \tFibroblasts \twere \tisolated \tfrom \tlungs \tof\tIPF\t\npatients \tand\tfrom \tnon-fibrotic \tcontrols. \tWe\tassessed \tthe\teffect \tof\tVEGF,\t\nPDGF-BB \tand\tbasic \tFGF\t(bFGF) \t\u00b1\tnintedanib \ton:\t(i)\texpression/activation\t\nof\tVEGFR, \tPDGFR, \tand\tFGFR, \t(ii)\tcell\tproliferation, \tsecretion \tof\t(iii)\tma-Respiratory\bResearch\b 2014,\b15:157\b \b IF\b3.382\ntrix\tmetalloproteinases \t(MMP), \t(iv)\ttissue \tinhibitor \tof\tmetalloproteinase\t\n(TIMP), \tand\t(v)\tcollagen.\t\nResults: \tIPF\tfibroblasts \texpressed \thigher \tlevels \tof\tPDGFR \tand\tFGFR \tthan\t\ncontrols. \tPDGF-BB, \tbFGF, \tand\tVEGF \tcaused \ta\tpro-proliferative \teffect \twhich\t\nwas\tprevented \tby\tnintedanib. \tNintedanib \tenhanced \tthe\texpression \tof\t\npro-MMP-2, \tand\tinhibited \tthe\texpression \tof\tTIMP-2. \tTransforming \tgrowth\t\nfactor-beta-induced \tsecretion \tof\tcollagens \twas\tinhibited \tby\tnintedanib.\t\nConclusion: \tOur\tdata\tdemonstrate \ta\tsignificant \tanti-fibrotic \teffect \tof\t\nnintedanib \tin\tIPF\tfibroblasts. \tThis\teffect \tconsists \tof\tthe\tdrug\u2019s \tanti-prolif -\nerative \tcapacity, \tand\ton\tits\teffect \ton\tthe\textracellular \tmatrix, \tthe\tdegrada -\ntion\tof\twhich \tseems \tto\tbe\tenhanced.\t\n1\tPulmonary \tCell\tResearch, \tDepartment \tof\tBiomedicine, \tUniversity \tHospital \tBasel, \tBasel \t4031,\t\nSwitzerland\n2\tClinics \tof\tRespiratory \tMedicine, \tUniversity \tHospital \tBasel, \tPetersgraben \t4,\tBasel \t4031,\nSwitzerland\nFull\tlist\tof\tauthor \tinformation \tis\tavailable \tat\tthe\tend\tof\tthe\tarticle.\nCell\bTissue\bRes\b (2014)\b358:717\u2013727\b \b IF\b3.333\nAbstract \tSomatostatin \t(SST) \tis\ta\tpeptide \thormone \tthat\texerts \tinhibitory\t\neffects \tmediated \tthrough \tbinding \tto\tspecific \tcell\tsurface \tG\tprotein-cou -\npled \treceptors, \tof\twhich \tfive\tdistinct \tsubtypes \t(SSTR1-SSTR5) \thave \tbeen\t\ncharacterized. \tOur\tstudy \tperformed \ton\tmouse \tcochlear \thair\tcells \tshows\t\nthe\texpression \tand\tlocalization \tof\tthe\tthree \treceptors \t(SSTR3-SSTR5) \tin\t\nwild-type \t(WT), \tsingle-knockout \t(SSTR1 \tKO)\tand\tdouble-knockout \tSSTR1/\nSSTR2 \t(DKO) \tmice. \tSimilar \tSSTRs \texpression \twere \tobserved \tin\tthe\tinner\thair\tcells \t(IHC), \touter \thair\tcells \t(OHC) \tand\tsupporting \tcells \tof\tcultivated \tP7\t\nmouse \torgan \tof\tCorti \t(OC)\texplants \tas\twell\tas\tin\tcultivated \tcochlear \tneu-\nroepithelial \tsupporting \tcells \t(NEsc). \tWe\tfound \tdifferences \tin\tthe\texpres -\nsion\tof\tSSTR3-5 \tin\tWT,\tSSTR1 \tKO\tand\tDKO\tmouse \tcochlea, \twhich \tmight \tbe\t\nexplained \tas\ta\tcompensatory \teffect \tin\tthe\tcochlea \tafter \tthe\tloss\tof\tSSTR1\t\nand/or \tSSTR2.\tExpression\t and\tlocalization\t of\tsomatostatin\t receptor\t types\t 3,\t4\tand\t5\tin\tthe\t\nwild-type,\t SSTR1\t and\tSSTR1/SSTR2\t knockout\t mouse\t cochlea\t\nVesna \bRadojevic1,2,\b&\bDaniel \bBodmer1,2Anti-fibrotic\t effects\t of\tnintedanib\t in\tlung\t fibroblasts\t derived\t from\t patients\t\nwith\t idiopathic\t pulmonary\t fibrosis\t\nKatrin \bE\bHostettler1,2,\bJun\bZhong1,\bEleni \bPapakonstantinou3,\bGeorge \bKarakiulakis3,\bMichael \bTamm1,2,\bPetra \bSeidel1,\bQingzhu \bSun1,\b\nJyotshna \bMandal1,\bDidier \bLardinois4,\bChristopher \bLambers5\band\bMichael \bRoth1\b\n1\tDepartment \tof\tBiomedicine, \tUniversity \tHospital \tBasel, \tPetersgraben \t4,\t4031 \tBasel, \tSwitzerland\t\n2\tClinic \tfor\tOtolaryngology, \tHead \tand\tNeck \tSurgery, \tUniversity \tHospital \tBasel, \tPetersgraben \t4,\t\n4031 \tBasel, \tSwitzerland\t\n26\t PUBLICATIONS \t DEPARTEMENT \tBIOMEDIZIN\nDBM \tFacts \t2|2015 \t Departement \tBiomedizinCancer\bImmunol\bRes\b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b \b\b 3(3);\b236\u201344;\bMarch\b2015\nAbstract\t\nCD40 \tstimulation \ton\tantigen-presenting \tcells \t(APC) \tallows \tdirect \tactiva -\ntion\tof\tCD8+\tcytotoxic \tT\tcells, \tindependent \tof\tCD4+\tT-cell \thelp. \tAgonis -\ntic\tanti-CD40 \tantibodies \thave \tbeen \tdemonstrated \tto\tinduce \tbene ficial\t\nantitumor \tT-cell \tresponses \tin\tmouse \tmodels \tof\tcancer \tand\tearly \tclinical\t\ntrials. \tWe\treport \there \tthat\tanti-CD40 \ttreatment \tinduces \tprogrammed\t\ndeath \tligand-1 \t(PD-L1) \tupregulation \ton\ttumor-in filtrating \tmonocytes\t\nand\tmacrophages, \twhich \twas\tstrictly \tdependent \ton\tT\tcells \tand\tIFN\u03b3.PD-\nL1\texpression \tcould \tbe\tcounteracted \tby\tcoadministration \tof\tantibodies\t\nblocking \tthe\tPD-1 \t(programmed \tdeath-1)/PD-L1 \taxis\tas\tshown \tfor\tT\tcells\tfrom \ttumor \tmodels \tand\thuman \tdonors. \tThe\tcombined \ttreatment \twas\t\nhighly \tsynergistic \tand\tinduced \tcomplete \ttumor \trejection \tin\tabout \t50%\t\nof\tmice \tbearing \tMC-38 \tcolon \tand\tEMT-6 \tbreast \ttumors. \tMechanistically,\t\nthis\twas\treflected \tby\ta\tstrong \tincrease \tof\tIFN\u03b3\tand\tgranzyme-B \tproduc -\ntion\tin\tintratumoral \tCD8+\tTcells. \tConcomitant \tCTLA-4 \tblockade \tfurther\t\nimproved \trejection \tof\testablished \ttumors \tin\tmice. \tThis\tstudy \tuncovers \ta\t\nnovel \tmechanism \tof\tacquired \tresistance \tupon \tagonistic \tCD40 \tstimulation\t\nand\tproposes \tthat\tthe\tconcomitant \tblockade \tof\tthe\tPD-1/PD-L1 \taxis\tis\ta\t\nviable \ttherapeutic \tstrategy \tto\toptimize \tclinical \toutcomes.Induced\t PD-L1\t Expression\t Mediates\t Acquired\nResistance\t to\tAgonistic\t Anti-CD40\t Treatment\nAlfred \bZippelius1,2,\bJens \bSchreiner1,\bPetra \bHerzig1,\band\bPhilipp \bM\u00fcller1\n1\tCancer \tImmunology \tand\tBiology, \tDepartment \tof\tBiomedicine, \tUniversity \tHospital \tBasel \tand\t\nUniversity \tof\tBasel, \tSwitzerland.\n2\tDepartment \tof\tMedical \tOncology, \tUniversity \tHospital \tBasel, \tSwitzerland.\nSelected\t publications\t by\tDBM\t members\nAbove \tyou\tcan\tfind\tthe\tabstracts \tof\trecent \tarticles \tpublished \tby\tmembers \tof\tthe\tDBM. \tThe\tabstracts \tare\tgrouped\t\naccording \tto\tthe\timpact \tfactor \tof\tthe\tjournal \twhere \tthe\twork \tappeared. \tTo\tbe\tincluded, \tthe\tpapers \tmust \tmeet \tthe\t\nfollowing \tcriteria:\t\n1.\tThe\tfirst\tauthor, \tlast\tauthor \tor\tcorresponding \tauthor \t(at\tleast \tone\tof\tthem) \tis\ta\tmember \tof\tthe\tDBM.\t\n2.\tDepartment \tof\tBiomedicine \tand\tUniversity \tof\tBasel \taffiliation \tmust \tbe\tmentioned \tin\tauthors \tlist\tas\tpublished \tby\t\t\n\t\t\t\t\tthe\tjournal.\n3.\tThe\tfinal\tversion \tof\tthe\tarticle \tmust \tbe\tavailable \t(online \tpre-publications \twill\tbe\tincluded \twhen \tthe\tcorrect \tvolume,\t\n\t\t\t\t\tpage \tnumbers \tetc.\tbecomes \tavailable).\nWe\tare\tfocussing \ton\toriginal \tpublications. \tDue\tto\tpage \tconstraints, \tabstracts \tof\tpublications \tthat\tappeared \tin\tlower\t\nranked \tjournals \tmay\tnot\tbe\table\tto\tbe\tincluded. \tReview \tarticles \tare\tgenerally \tnot\tconsidered, \tunless \tthey \tappeared \tin\t\nthe\tvery \ttop\tjournals \t(e.g. \tCell,\tScience, \tNature, \tNEJM, \tetc.). \tThe\tfinal\tdecision \tconcerning \tinclusion \tof\tan\tabstract \twill\t\nbe\tmade \tby\tthe\tchair \tof\tthe\tDepartment \tof\tBiomedicine.\nIf\tyou\twish \tthat\tyour \tarticle \twill\tappear \tin\tthe\tnext \tissue \tof\tDBM \tFacts \tplease \tsubmit \ta\tpdf\tfile\tto\tthe\tDepartmental\t \t\nAssistant, \tManuela \tBernasconi: \tmanuela.bernasconi@unibas.ch\nDeadline \tfor\tthe\tnext \tissue \tis\tAugust \t31,\t2015\nT arator  (\u0442\u0430\u0440\u0430\u0442\u043e\u0440)\nRezeptmenge f\u00fcr: 4 Personen\nZeitbedarf: 20 Minuten\nT arator ist eine erfrischende, sommerliche und kalt servierte \nGurkensuppe aus dem Balkanraum. \nZutaten: \n500 ml kalter (bulgarischer) Joghurt 300 ml kaltes Wasser \n1 Salatgurke \n1\u20135 Knoblauchzehen 1 Bund Dill 3 EL kaltgepresstes, natives Oliven\u00f6l Weissweinessig frisch gemahlener Pfeffer (optional) \nSalz \nKochgeschirr: \n1 Schneebesen, 1 grobe Reibe, 2 Sch\u00fcsseln Zubereitung: \nDie Salatgurke unter kaltem Wasser abbrausen und mit einer groben Reibe in eine grosse Sch\u00fcssel reiben. Den Joghurt und das Wasser mit einem Schneebesen gut verr\u00fch-\nren. \nDie Knoblauchzehen sch\u00e4len und fein zerreiben, etwas mit Salz bestreuen. Die restlichen Zutaten, ausser dem Essig, mit dem Joghurt und der Gurke gut vermengen. Die Suppe mit dem Weissweinessig abschmecken und kalt ser -\nvieren. \nBeilagen: \nBaguette oder Pide \nVarianten: \nWeniger Wasser nehmen.DBM \tFacts \t2|2015 \t Departement \tBiomedizinDEPARTEMENT\nBIOMEDIZIN  \nHEBELSTRASSE\nFranziska \bUhlenbrock\nCancer \tImmunologyMax\bGay\nTissue \tEngineeringXiomara \bBanholzer\nStabNicola \bAceto\nCancer \tMetastasis\nOliver \bGorka\nMolecular \tImmune\nRegulation\nLena \bSiewert\nExperimental \tVirology28\t EINTRITTE \t|\tNEW \tCOLLEAGUES \t DEPARTEMENT \tBIOMEDIZIN\nDEPARTEMENT\nBIOMEDIZIN  \nPETERSPLATZ\nMukesh \bPunjabi\nCardiovascular \tMolecular\t\nImaging\nAusserdem \bhaben \bangefangen:\nDEPARTEMENT\b\nBIOMEDIZIN\b\nHEBELSTRASSE\nShefaa \bAl\bAsfoor\nDiabetes \tResearch\nMarwa \bAlmosailleakh\nChildhood \tLeukemia\nMerrina \bAnugraham\nOvarian \tCancer \tResearch\nChristoph \bBachmann\nPerioperative \tPatient \tSafetyBeatrice \bBolinger\nTransplantation \tImmunology\n&\tNephrology\nJeanne \bdu\bFay\bde\bLavallaz\nMyocardial \tResearch\nJan\bEckhardt\nPerioperative \tPatient \tSafety\nSara \bEl\bAshkar\nCell\tand\tGene \tTherapy\nMaria \bFlorescu\nChildhood \tLeukemiaFranco \bGrimolizzi\nPrenatal \tMedicine\nFabiana \bGullotta\nTissue \tEngineering\nMichelle \bH\u00fcgle\nTierstation\nFerdinand \bJagot\nClinical \tNeuroimmunology\nAnne \bKistner\nTranslational \tImmunology\nJanina \bEsther \bLinnik\nApplied \tMicrobiology \tResearchDEPARTMENT \tOF\tBIOMEDICINE\t EINTRITTE \t|\tNEW \tCOLLEAGUES\t 29\nDBM \tFacts \t2|2015 \t Department \tof\tBiomedicineDEPARTEMENT\b\nBIOMEDIZIN\b\nHEBELSTRASSE\nAlexander \bLunger\nCell\tand\tGene \tTherapy\nEmilia \bMeyer\nOcular \tPharmacology \tand\nPhysiology\nStefan \bOtt\nInfection \tBiology\nGiuseppe \bPisani\nCardiac \tSurgery \tand\tEngineering\nEleonora \bRossi\nTissue \tEngineering\nSebastiano \bSansano\nExperimental \tImmunology\nStefan \bSchaub\nTransplantation \tImmunology\n&\tNephrology\nSebastian \bSchmitz\nChildhood \tLeukemia\nNageswara \bRao\bTata\nExperimental \tHematology\nRoberta \bVisone\nCardiac \tSurgery \tand\tEngineering\nCaroline \bWehmeier\nTransplantation \tImmunology\n&\tNephrology\nBibin \bYesodha \bSubramanian\nPrenatal \tMedicineDEPARTEMENT\b\nBIOMEDIZIN\b\nKLINGELBERGSTRASSE\nMari \bNakamura\nBrain \tand\tSound\nYanwei \bTan\nMolecular \tNeurobiology \tSynaptic\t\nPlasticity\nDEPARTEMENT\b\nBIOMEDIZIN\b\nMATTENSTRASSE\nMathieu \bBerthelot\nCancer- \tand\tImmunobiology\nStephanie \bBuenger\nCancer- \tand\tImmunobiology\nVerena \bHurst\nCancer- \tand\tImmunobiology\nTaya \bKueng\nMolecular \tGenetics\nFabiana \bLueoend\nTumor \tBiology\nRobert \bReinhardt\nDevelopmental \tGenetics\nErnst \bEmanuel \bStrehler\nTumor \tBiology\nFengyuan \bTang\nTumor \tBiologyStefan \bWeis\nMolecular \tGenetics\nSimon \bZinkhan\nDevelopmental \tand\tMolecular\nImmunology\nDEPARTEMENT\b\nBIOMEDIZIN\b\nPESTALOZZISTRASSE\nElisabeth \bEppler\nMusculoskeletal \tResearch\nDEPARTEMENT\b\nBIOMEDIZIN\b\nPETERSPLATZ\nFranziska \bAckermann\nMolecular \tVirology\nLilian \bQuero\nExperimental \tRheumatology\nPeter \bReuther\nExperimental \tVirologyAusserdem \bhaben \bangefangen:\nCongratulations\nEnea\bDi\bMarco\nGeboren \tam\t24.05.2015Kurt\bJonas\bSteinl\nGeboren \tam\t08.05.2015\nDBM \tFacts \t2|2015 \t Departement \tBiomedizin30\t BABYS \t DEPARTEMENT \tBIOMEDIZIN\nDas DBM gratuliert ganz herzlich!\nHerzlich \n willkommen, \nallerseits! Iris\bTheodouli\bThanasopoulou\nGeboren \tam\t19.03.2015Lilou\bDasen\nGeboren \tam\t14.12.2014\nIris\bEva\bZippelius\nGeboren \tam\t02.03.2015Elisaveta\bKalinichenko\nGeboren \tam\t10.03.2015\nDBM Facts 2|2015  Department of BiomedicineDEPARTMENT OF BIOMEDICINE  FREIZEIT / FREETIME  31\nMalen mit Licht\nIm Laufe eines Tages \u00e4ndert sich durch \nden Weg der Sonne das Licht deutlich. Besondere Stimmungen lassen sich in der Zeit um Sonnenaufgang und Sonnen-untergang einfangen. Wegen des relativ flach einfallenden oft gold-gelben Lichtes hat sich die Zeit nach dem Aufgang und vor dem Sonnenuntergang als \u00abgoldene Stunde\u00bb ihren Namen gemacht (Bild 1).\nDa ich als PhD Student am DBM arbeite, komme ich haupts\u00e4chlich in den Morgen- oder Abendstunden zum Fotografieren. Oft sind es die Hunderunden, auf denen ich mit der Kamera unterwegs bin. Daher ist mein kleines Beagle-Meitli \u00abBisou\u00bb wohl mein h\u00e4ufigstes Motiv. Mit ihr als Model versuche ich ab und an auch, gezielt Re-geln der Fotografie zu brechen. Eine die-ser Regeln lautet zum Beispiel \u00abFotogra-fiere nie gegen die Sonne\u00bb. Hintergrund dieser Regel ist, dass jedes Objekt seinen Schatten in Richtung Kamera wirft und so seine Struktur und Farbe in eben diesem Schatten verschwinden. Mit maximal ge-schlossener Blende kann man jedoch sehr stimmungsvolle Bilder erzeugen, in denen alle Dinge wie ein Scherenschnitt vor dem \nFarbverlauf des Himmels wirken (Bild 2).\nDBM Facts 2|2015  Department of BiomedicineDas Licht um die Mittagszeit wird oft als schwierig bezeichnet, da sich durch die hochstehende Sonne sehr \nscharfe Schatten bilden. Vor allem bei der Personenfotografie sorgt das f\u00fcr Probleme, weil die Augen oft im Schatten der Augenbrauen verschwinden. Nachts und in dunklen R\u00e4umlichkeiten stellt einen die Abwesen-heit von Licht vor ganz andere Herausforderungen. Hierzu ein kleines Paradoxon: Interessanterweise kann ein frontal ausgerichteter Blitz zur Mittagszeit die Gesichtsschatten wunderbar verschwinden lassen, wird aber in Kirchen und anderen schummrigen Situationen zum echten Stimmungskiller.So \u00fcbersetzt Wikipedia das Wort Fotografie (phot\u00f3s = Licht, graphein = malen) aus dem Griechischen.Nat\u00fcrlich muss man sich gerade in der \nSchweiz mit all ihren Sehensw\u00fcrdigkeiten nicht auf den eigenen Hund als Motiv be-schr\u00e4nken. Mit dem mediterranen S\u00fcden, dem Mittelland und den Alpen warten vie-lerlei Landschaften darauf, entdeckt zu werden. Auf unseren Wandertouren am Wochenende bin ich dann mit einem Weit-winkelobjektiv unterwegs. Dieses hilft,  die Szenerie eines besonderen Aussicht-punktes im Panoramaformat aufzuneh-men. Nun gibt es schon allerlei Bilder von immer denselben Bergspitzen, aber mit dem Mond im R\u00fccken und den Sternen am Himmel, werden dieselben Berge wie-der interessanter (Bild 3).\nMalen mit Zeit\nAm Tag reichen dem Fotoapparat oft Se-kundenbruchteile um gen\u00fcgend Licht zu sammeln und eine Szene festzuhalten. Der Rotmilan von Bild 4 ist in den W\u00e4ldern um die Blindenhundeschule in Allschwil zu Hause. Oft kreisen drei oder vier von ih-nen \u00fcber den Feldern von Allschwil. Eine eintausendstel (1/1000) Sekunde hat ge-reicht, um ihn dabei aufzunehmen, wie er jene Beute unter die Lupe nimmt, die er kurz vorher bei einem Sturzflug aufgegrif-fen hat.32 FREIZEIT / FREETIME  DEPARTEMENT BIOMEDIZIN\nDBM Facts 2|2015  Departement BiomedizinNeben dem Licht ist ein zweiter Faktor f\u00fcr die Fotografie von grosser Bedeutung. Dieser Faktor ist die Zeit. Gemeint ist die Belichtungszeit, die man der Kamera l\u00e4sst, um das Bild aufzunehmen.\nUnter anderem ist dieses Bild auch deswegen so scharf, weil die Aufnahmezeit so kurz war, dass Bewe-\ngungen der Kamera kaum eine Rolle gespielt haben. Je l\u00e4nger die Belichtungszeit, desto wichtiger ist, dass der Fotograf die Kamera still h\u00e4lt. Ge\u00fcbte Fotografen schiessen scharfe Bilder aus der Hand bis zu einer Belichtungszeit von 1/25 Sekunden. F\u00fcr alles, was l\u00e4nger dauert, legt man die Kamera besser auf eine Mauer oder schraubt sie auf ein Stativ. Dann sind den Belichtungszeiten keine Grenzen mehr gesetzt. Belichtungszeiten von mehreren Sekunden bis zu Minuten sind mit Stativ kein Problem mehr \u2013 der Akku der Kamera sollte dann aber geladen sein.DBM Facts 2|2015  Department of Biomedicine\n30 Sekunden lang hat die Kamera Licht \nf\u00fcr das Bild am Strand von Lausanne (Bild 5) gesammelt. Wer genau hinschaut, kann auch die Sterne des Sternbildes Ori-on erkennen. Um Sterne zu fotografieren, braucht man schon einen sehr sicheren Stand. Oft sind trotz Stativ einige Bilder verwackelt. Diese wandern in der Regel umgehend ins Datennirvana.\nMit ein bisschen Fantasie und \u00dcbung kann \nman aber auch bei l\u00e4ngeren Belichtungs-\nzeiten mit Bewegung spielen. Bild 6 ist entstanden, als ich vom Hafen von Laus-anne aus ein Bild von Evian-Les-Bains machen wollte. Irgendwann kam dann die F\u00e4hre dazwischen. Aufgrund ihrer Bewe-gung allerdings ist die F\u00e4hre unsichtbar, w\u00e4hrend ihre Lichter sehr deutlich zu se-hen sind.\nSpass macht auch, w\u00e4hrend einer l\u00e4n-geren Belichtungszeit aus dem Bild he-raus oder herein zu springen (Bild 7). Das \nErgebnis ist  eine Art Doppelbelichtung \naus zwei Bildern: Ein Bild von einer Person liegt auf einem anderen Bild.DEPARTMENT OF BIOMEDICINE  FREIZEIT / FREETIME  33\nDBM Facts 2|2015  Department of BiomedicineNat\u00fcrlich funktionieren solche Experimente nicht immer beim ersten Mal.  Oft genug stellt man sich das Ergebnis auch viel toller vor, als es am Ende im Bild aussieht. So oder so lernt man eigentlich immer wieder etwas dazu und als Ablenkung von der Arbeit reicht es alle mal.Ronny NienholdDBM Facts 2|2015  Departement Biomedizin34 SEASON  DEPARTEMENT BIOMEDIZIN\nHei senn eich dahaam -\nWelcome to Germany\u2019s oldest city Trier\nWelcome to Trier, founded over 2000 years ago as \nAugusta Treverorum, today the oldest city of Ger -\nmany. The city is located in the west of the state Rhineland- Palatinate, very near to the borders of Luxembourg and France. It lies on the bank of the river Moselle, in a valley surrounded by vineyards \nand embedded among the two mountain ranges \nof Eifel and Hunsr\u00fcck. Its placement is one reason for Trier being a well known locality for wine con-noisseurs. If you find time to go along the riverside by bike you can visit hundreds of villages famous for local wine makers, producing and selling their own wine at small local festivals. The city has approximately 100.000 inhabitants making it very cosy. It is also a university city. \nThe University of Trier, or, as it is better known, \nthe Karl Marx-University, is known for many hu-manity disciplines, especially focussing on law and economics. Due to the high number of stu-dents joining the university every year, Trier can therefore be called a students\u2019 city with an above average number of bars. The reason for the univer -\nsity\u2019s name is the fact that Trier is the birth place of the famous German philosopher, economist and social-critic. His manifest is one of the pillars of the Chinese state-structure. As a result many Chinese Test your knowledge about Trier \u2013 find the answers while reading\nWhy do you meet so many Chinese people with cameras in Trier?\n.............................................................Which holy relic is to be found in the cathedral?\n.............................................................\nHow could Trier beat both the UEFA Cup and Champions league winners in one season?.............................................................What is the main drink of the locals?.............................................................What is the most popular phrase in local Trier slang?\n.............................................................\nWhat are the main ingredients of a simple but delicious Trier specialty?.............................................................DBM Facts 2|2015  Department of BiomedicineDEPARTMENT OF BIOMEDICINE  SEASON  35\nHei senn eich dahaam -\nWelcome to Germany\u2019s oldest city Trier\npeople come to visit Trier every year and the house \nin which he was born is of particular interest and is always surrounded by a lot of Chinese travel-lers taking pictures. The school that Karl Marx at-tended still exists and is a well-known secondary school in Trier today.   \nThe Roman remains in Trier are listed as a UNESCO \nworld cultural heritage site and consist of 9 impor -\ntant historical sites. The most important one, and at the same time the town\u2019s landmark, is the black gate \u201cPorta Nigra\u201d, a former Roman gate that kept enemies outside of the inner city area. Trier was founded at least 16 years before Christ. At the time, where Romans located and built up the city, it de-veloped to be a focus point of the west- Roman Em-pire. Nowadays one can still visit the throne room, \namphitheatre and some Roman baths. The Romans \nwere known to already be very experienced and modern in their technical constructions which can be seen, for example, in the ancient remains of an under floor heating system.\nToday the ground level of whole city is located \nseveral meters above that of old Roman times. The locals say that whenever they want to build a new house, and they have to dig a hole first, there will be always be some Roman items found that \nthen delay the construction work \u2013 the city is still \nfull of ancient material. Sometimes that can even be something precious. In 1993, a hoard of gold coins weighing 18.5kg was found during building works in the center of Trier. It is the largest collec-tion of gold coins from the great Roman empire and therefore a main exhibit in the historical mu-seum of Trier. Another example of how old Roman walls and constructions have impaired the modern city structure is to be found in a big glassy cube on a central yard in the inner city. During street building works in the late 1980s a large area full of antique bath-walls was found. In the early 1990s \nit was decided to integrate the discovery into the \ncity-picture by covering it with a big glass build-ing. Today it is used for many official festivals and formal receptions.\nNext to the Roman sights, we have the oldest bish-\nops\u2019 cathedral where the holy robe worn by Jesus shortly before his crucifixion, is exhibited. It is kept in a reliquary and cannot be viewed most of the time. The last pilgrimages to see the robe took place \nin 2012, 1996 and 1959. In front of the cathedral you \ncan find the cathedral stone. A famous legend says that in the middle ages the devil himself was asked \nDBM Facts 2|2015  Departement Biomedizin36 SEASON  DEPARTEMENT BIOMEDIZIN\nto help build a bar, but, when he saw that he had \nhelped to build a church, he wrathfully dropped the last stone in front of the cathedral where it still lies today. It is like a magnet for many tourists.\nAfter an exhausting sightseeing trip, we can rec-\nommend the beautiful wine-house \u201eOechsle\u201c in \nthe city-center to get in touch with the bright wine-culture of Trier. Here you can combine a relaxing wine-tasting session with some delicious food.In addition, during the main grape harvest time at the end of July / beginning of August there are a lot of large local wine-festivals taking place. There are also the old city festival and the pure wine-fes-tivals at the riverside area of \u201cZurlauben\u201d and in the little wine producing village of \u201cOlewig\u201d. Both are great opportunities to taste local wine and lis-\nten to all kinds of live-music embedded with a typ-\nical wine-yard flair. Although we have such a large choice of different wines, the locals have chosen a specific kind of cider called \u201cViez\u201d as their main drink. We have included a nice recipe of a typical favourite dish of the most locals as well, that can be accompanied by either wine or cider. Pretty easy and very tasty.\nFor all of the impassioned sport fans among you, \nTrier is probably not the center of action in the field of international sports, although it hosts some im-portant sport teams.\nIn addition to a successful woman handball club \nin the first national league, and a basketball club in the second national league, SV Eintracht Trier 05 is the number one soccer club in Trier. Honest-ly, the club does not play a great role in the bright history of the German Bundesliga, but it is prob-ably the only club that beat both the winner of the UEFA CUP FC Schalke 04 and the winner of the UEFA Champions league Borussia Dortmund 09 in the season 1997/1998. How was that possible? Trier reached the semi-final of the national DFB \nSoccer cup during that season. It is considered \nas the greatest Cup-success in the club history. The most valuable player at that time for Trier was Rudi Th\u00f6mmes (1986 \u2013 2004). He is prob-ably regarded as one of the sym-bolic figures of the traditional club in \nTrier. Everyone in \nTrier knows him and his important goal against Dortmund in 1998.\nIf you get to know some typical locals, you will find \nthem to be generally a bit stubborn and closed, but also very social on the other side. As in Basel, we celebrate \u201cFastnacht\u201d in an extraordinarily festive manner. Everyone wears a costume and goes out on the streets to enjoy the parades, collect sweets and enjoy some drinks with friends. If you listen \ncarefully to the locals, you will hear that they speak \na strong dialect when compared to high-German. \nDBM Facts 2|2015  Department of BiomedicineDEPARTMENT OF BIOMEDICINE  SEASON  37\nIf you do not know what to say, but you would like \nto be polite, ask \u201cAnd?\u201d and someone will reply with \u201cYes\u201d and be very happy that you contribut-\nFlorian & Katharina\nThe authors of this article were both born in and \ngrew up in Trier. They met 10 years ago in school and attended biology as one their main classes during their preparation for their university-en-\ntrance diploma. Katharina studied molecular bi-\nology in Maastricht (NL) whereas Florian studied biosciences in Giessen (D). In 2012, they met again during holidays in their hometown in the famous students\u2019 bar \u201cSimplicissimus\u201d where Katharina successfully tried to convince Florian with a glass of \u201cViez\u201d to move to Basel.Recipe:\u2002Recipe:\u2002Recipe:\u2002Recipe:\u2002Recipe:\u2002Recipe:\u2002Recipe:\u2002Recipe:\u2002\u2002Recipe:\u2002Recipe:\u2002Recipe:\u2002\nTrierer\u2002\u201c\u2002Teerdisch\u201d\n1/2\u2002\u2002kg\u2002sauerkraut\n1\u2002kg\u2002potatoes\u2002(that\u2002we\u2002call\u2002\u201cgrombeeren\u201d)some\u2002little\u2002blood\u2002and\u2002liver\u2002sausages\nsalt\nCook\u2002potatoes\u2002and\u2002sauerkraut\u2002separately.\u2002Mash\u2002the\npotatoes\u2002and\u2002mix\u2002it\u2002with\u2002sauerkraut,\u2002add\u2002a\u2002bit\u2002salt.Heat\u2002up\u2002the\u2002sausages\u2002and\u2002serve\u2002them\u2002with\u2002the\u2002mix.Alternatively:\u2002You\u2002can\u2002have\u2002meatballs\u2002or\u2002liver\u2002dumplings.\ned. If you would like to express any deviation from \nthe norm (good, bad, tasty, awful), you should try it with \u201coh leck\u201d. Really, try it!Recipe:\u2002Recipe:\u2002Recipe:\u2002Recipe:\u2002Recipe:\u2002Recipe:\u2002Recipe:\u2002Recipe:\u2002\u2002Recipe:\u2002Recipe:\u2002Recipe:DBM Facts 2|2015  Departement Biomedizin38 SEASON  DEPARTEMENT BIOMEDIZIN\nGrosse Ferien!\nWir haben l\u00e4ngst verlernt, was das Aus in Auszeit bedeutet\nEin Pl\u00e4doyer f\u00fcr einen neuen Urlaub\nDr\u00fcben im Solarium ist ein neues Schild im Schau-\nfenster. \u00abFaken Sie das Urlaubsgef\u00fchl!\u00bb steht darauf. Daneben ist ein Paar in Badehosen freigestellt, das \nsich gegenseitig auf die knusprige Kruste schaut. \nDen Urlaub vort\u00e4uschen, darauf muss man erst mal kommen. Noch komischer ist, was das Schaufen-ster eigentlich sagt: Urlaub muss was abwerfen. Wozu wegfahren, wenn man nicht mindestens als ein anderer wiederkommt? Dieser verbreitete An-spruch ist schon Teil unserer Urlaubskrise. Ein ande-rer ist jene vermaledeite Woche vor dem Urlaub. F\u00fcr gew\u00f6hnlich wird das ja die schlimmste Arbeitswo-\nche des ganzen Halbjahrs. Der Klumpen Unbeant-\nwortetes und Aufgeschobenes, den man \u00fcber Mo-nate jongliert hat, jetzt soll er doch noch schwinden. Alle Kan\u00e4le, auf denen im B\u00fcroalltag gesendet wird, m\u00fcssen vorbereitet sein auf die Unterbrechung, sie sollen m\u00f6glichst wenig weiterleiten. Die Angst vor \nder unw\u00e4gbaren St\u00f6rung des heiligen Urlaubs kennt \nnur eine Abhilfe: Alles fertigmachen. Deshalb ist die letzte Arbeitswoche so produktiv wie drei normale, man schreit, finished, delegiert wie nie und kollabiert final, weil noch was Neues reinkommt.Gerade Menschen, die sich ihren Arbeitsalltag be-sonders frei eingerichtet haben, erleben die letzten Tage vor den Ferien als qu\u00e4lendes Endzeit-Szenario. \nVielleicht, weil das eine der wenigen Deadlines ist, \ndie nicht aufgeschoben werden kann. Sp\u00e4t am Frei-tagabend, wenn alle anderen schon gegangen sind, formuliert man im ungewohnten Beisein des Reini-gungspersonals die Abwesenheitsnotiz. Meist wird es ein harsches Konstrukt aus Selbstbezichtigung und Ersch\u00f6pfung: \u00abE-Mails werden nicht gelesen / . . . nur in sehr dringenden F\u00e4llen ist da der Kollege / . . . meine geplante R\u00fcckkehr am. . . \u00bb Erst wenn es \nklingt, als beg\u00e4be man sich nackt ins Herz der Fin-\nsternis, ist es drastisch genug, erst dann wird jeder verstehen, was los ist: Man ist mal kurz nicht da. Man macht Urlaub. Herrgott, ist das anstrengend.\nVor allem im Sommer, denn das ist ja der Vorzei-\ngeurlaub, der Grand Slam der Freizeit, Sommerur -\nlaub muss liefern. M\u00f6glicherweise haben wir diese \nfixe Idee von unseren Eltern \u00fcbernommen, vielleicht aber auch einfach vom Dudelradio. Dort wird das Mantra von der b\u00f6sen Arbeit und dem tollen Urlaub \njeden Tag zementiert. Die Anrufer, die Moderatoren, \ndie H\u00f6rer im Stau singen es non-\nstop im Chor: Montag b\u00e4h, Wo-chenende hurra, Arbeit b\u00e4h, Urlaub hurra und erst recht der Sommer -\nurlaub, hee-ey, ab in den S\u00fcden! \nDer Kontrast zwischen Arbeitswelt \nund Freiheit wird da jeden Tag ver- st\u00e4rkt. Wozu eigentlich, wem n\u00fctzt diese Propaganda? Wer es auf dem Weg zu seiner Arbeit oft genug \nh\u00f6rt, hasst selbige pflichtgem\u00e4ss \nund setzt sich f\u00fcr die n\u00e4chsten Urlaube irre Erlebnis-Benchmarks. Ein Teufelskreis \u2013 je mehr man den \nUrlaub \u00fcberh\u00f6ht, desto unwahr -\nscheinlicher wird, dass er die Er -\nwartungen erf\u00fcllt, desto schlechter \nerholt kommt man nach Hause, \nDBM Facts 2|2015  Department of BiomedicineDEPARTMENT OF BIOMEDICINE  SEASON  39\ndesto schneller ist die Arbeit wieder b\u00e4h. Recht bald \nhat einen das System so weit, dass man denkt, das Mallorca-Herumliegen, das Gran-Canaria-Wandern, das Thailand-Tingeln w\u00e4re das wahre Leben, das, \nwof\u00fcr man arbeitet. Was dort eigentlich passiert, \nist aber banal: Man schaltet sich f\u00fcr zehn Tage in den gleichen Urlaubsmodus wie die Ger\u00e4te um ei-nen herum. Der Urlaubsmodus ist aber auch nur das \nArbeitsprogramm in einer soften, bunten und we-\nnig belastbaren Beta-Version, massenhaft kopiert. In diesem Programm sammeln wir Auslandserfah-rung, verbessern Sprachkenntnisse, optimieren Sport- und Hobby-F\u00e4higkeiten und kurbeln den De-\nvisenhandel an. Zur\u00fcck im B\u00fcro fahren wir aus dem \nStandby wieder auf die Arbeitsoberfl\u00e4che hoch. Wir waren nicht wirklich aus. Das Urlauben, wir beherr -\nschen es eigentlich nicht gut. Der gr\u00f6sste Ausbruch besteht doch meistens darin, dass man sich schon \num f\u00fcnf Uhr nachmittags einen Longdrink servieren \nl\u00e4sst oder selbst einschenkt. Da sitzt man dann und denkt von sich selbst als entschleunigter Person.Es muss sich also etwas \u00e4ndern. Nicht nur wegen der krampfhaft proaktiven Reiserei, nicht nur, weil \ndie Studien sagen, dass sich vom f\u00fcnften Tag an \n\u00fcberhaupt erst ein vager Erholungseffekt einstellt, der dann aber im schlechtesten Fall nach drei Wo-chen B\u00fcro schon wieder weg ist. Nein, wir m\u00fcssen unsere Urlaubsidee \u00fcberarbeiten, weil sie die letzten sechzig Jahre nicht hinterfragt wurde. Wir absolvie-\nren ihn letztlich immer noch so wie Heinz Erhardt, \nmit \u00fcberf\u00fclltem Kofferraum und Pepita-Ehekrach, mit einem wohldosierten Hauch Exotik und buntem letzten Abend. Eine muffige, spiessige Kurzflucht. \nDabei wissen wir eigentlich, was der bessere Urlaub \nw\u00e4re. Jeder von uns tr\u00e4gt ihn als vage Erinnerung in sich, als verblichenes Polaroid eines Sommers aus l\u00e4ngst vergangener Zeit. Dieses Polaroid, es ist eine unscharfe Melange aus allen Sommerferien, in de-\nnen wir vielleicht zwischen sechs und zw\u00f6lf Jahre \nalt waren und die Zeitl\u00e4ufte nur von vagem Interes-se. Sechs Wochen Schulferien sind ja eine kolossale Sache, die meisten gestatten sich sp\u00e4ter nie wieder \nDBM Facts 2|2015  Departement Biomedizin40 SEASON  DEPARTEMENT BIOMEDIZIN\nim Leben eine solche Masse undefinierter Zeit am \nSt\u00fcck, eine Spanne, in die man nichts hineintr\u00e4gt und aus der man nichts wieder mitbringen muss als \nsich selbst. Verpflichtungen? Zero! Man diffundierte \nin den Sommer, der August war wie dunkler Honig in einem sehr gro\u00dfen Stundenglas, die Tage, die Wochen, man konnte sie einfach vergessen. Sicher, die Eltern entf\u00fchrten einen vielleicht in ihren Eltern-Urlaub, zwei Wochen, in denen sie um f\u00fcnf Uhr einen Longdrink f\u00fcr sich und ein Eis f\u00fcrs Kind bestellten. \nAber dann ging es zur\u00fcck, in die hitzestillen St\u00e4dte \nund D\u00f6rfer mit ihrem angez\u00e4hlten Gartengr\u00fcn und dort war man dann endg\u00fcltig: lose, frei.\nMan brauchte nicht viel. Das immer gleiche Hand-\ntuch, mit dem man zum Freibad radelte, die paar \nFreunde, die \u00e4hnlich sommersediert neben einem trotteten und ohne Verabredung am Steg sassen, einen Fu\u00dfball vielleicht, ein bisschen Taschengeld. \nDas Wichtigste stellte sich unbemerkt ein: goldene \nLangweile und ein Anflug von Ewigkeit. Nicht so sehr, wenn man sich animieren l\u00e4sst, die Alpen \u00fcberquert, Wellen surft, auf Lanzarote Pilates lernt und Jetski ausleiht, erf\u00e4hrt man etwas \u00fcber sich, sondern wenn man sich gepflegt langweilt. Wir erreichen den Zu-\nstand echter Langeweile sp\u00e4ter im Leben aber nicht \nmehr, sie hat keine Lobby, und all die Systeme, die uns umgeben, sind darauf angelegt, sie zu bek\u00e4mp-fen. Aber die gute Langeweile der Sommerferien, die Anfang vierte Woche in der endlosen Vormit-\ntagsstille des Elternhauses einsetzte, begleitet nur \nvom Brummseln der Stubenfliege am Fenster, war sie es nicht, die uns wieder auf null stellte? W\u00e4re sie nicht auch heute den komischen Verben n\u00e4her, die wir jedem Urlaub andichten: Runterkommen, \nabschalten, ausklinken? Sind damit nicht eigentlich \nTage gemeint, in denen die gr\u00f6sste Aufregung das Trocknen der eigenen Fu\u00dfspuren am sonnenwar -men Beckenrand ist? Und zwar: Richtig viele Tage, richtig viele trocknende Fussspuren? Im Spiel \ngedacht \u2013 wie liesse sich dieses \nSommerferiengef\u00fchl f\u00fcr Erwach-sene wieder herstellen? Wichtig \nscheint die Einheit von Ort, Zeit \nund Handlung zu sein, was zuf\u00e4llig \nder Aristotelischen Forderung f\u00fcr \nein gutes Drama entspricht. Aber als Kind war man eben meist an seinen Ort gebunden, man plante nicht in die Zukunft, man handelte \nlokal und flog immer auf Sicht. Dann die Vertrautheit der Umgebung! Erst wenn die F\u00fcsse die Trampel-pfade auch in der D\u00e4mmerung von alleine finden, erst wenn man eins mit der Topografie ist und alle Codes kennt, l\u00e4sst sich doch ruhig ich sein.\nDas bedeutet nicht, dass man in der Vision von er -\nwachsenen Sommerferien nicht verreisen soll, aber \ndann bitte auch mal: Irgendwo ankommen. Wir spre-chen schliesslich von Ferien, nicht von einer Reise, nicht von einem Trip, nicht von einem Hopping. Zwei Wochen sind f\u00fcr Vertrautheit an einem neuen Ort zu \nkurz, wir sollten dieses Format endlich aufbrechen. \nVier Wochen an einen Ort! Und das die n\u00e4chsten f\u00fcnf Sommer! Ist nicht so ungew\u00f6hnlich, Franzosen und Italiener halten es seit jeher so. Das merkt man de-ren Volkswirtschaften auch an, k\u00f6nnte man frotzeln. \nAber Amerikaner und Japaner machen so gut wie \nnie Urlaub und wirken wirtschaftlich auch ziemlich ausgebrannt.\nUnd vor hundertzwanzig Jahren waren wir urlaubs-\nm\u00e4ssig ja schon mal moderner, Stichwort Som-\nmerfrische. Sommerfrischen hiessen urspr\u00fcnglich nur die Behausungen, die zu eben jenem Zweck aufgesucht wurden. Einfache Bauernstuben, kleine H\u00e4user, schlichte Quartiere. Man begab sich dort-\nhin, bevor der Sommer seinen Zenit erreichte, und \ndas war das H\u00f6chstmass an Bewegung, das man die n\u00e4chsten Wochen oder Monate auf sich nahm. Der Rest ergab sich. Man fuhr nicht in die Sommer -\nfrische, um ein anderer zu werden. Es war nicht die \nkrasse Flucht, die heutigen Urlauben anhaftet, nicht \ndas unbedingte Bestreben, f\u00fcr vierzehn Tage alles \nan Alltag, Klamotte, Sprache, Nachbarn hinter sich \nzu lassen. Nein, der Sommerfrischler blieb, wer er war, erledigte weiterhin Korrespondenz, kleidete \nsich weiterhin adrett, lud ein und besuchte reihum, \nDBM Facts 2|2015  Department of BiomedicineDEPARTMENT OF BIOMEDICINE  SEASON  41\nes gab ein paar Freunde, man lernte andere kennen, \nein leichter Flirt, ein bisschen Tennis. Und weil man Jahr um Jahr wiederkam, wurde aus dem Fremdeln \ndes ersten Aufenthalts mit den Jahren ein gebor -\ngenes Streicheln, eine Sommerheimat.\nLuftver\u00e4nderung ist ein sch\u00f6nes Wort. Mal ehrlich, \nwie viel Abenteuer mehr braucht der Mensch, als \ndass die Luft morgens ein bisschen verheissungs-\nvoller riecht als sonst? Und daf\u00fcr reichte schon im-\nmer eine Fahrt mit dem Eilzug aus der Stadt hinaus. \nWeil es kein Dudelradio gab, war die Arbeit damals vielleicht auch nicht ganz so verp\u00f6nt. K\u00fcnstler prak-\ntizierten im Urlaub einfach weiter, Fabrikbesitzer fuh-\nren donnerstags zur Familie aufs Land und kehrten \nam Sonntag in die Stadt zur\u00fcck, wer kein Geld hatte, \nhalf den Bauern bei der Ernte und schlief im Heu. Ziel war nicht das Ziel, sondern die verbrachte Zeit. Der vergessene Schriftsteller Ludwig Steub notierte \ndamals: Jeder Torwart, jeder Milchmann geht aufs \nLand, und selbst die abgelegensten Bergh\u00f6fe wer -\nden aufgesucht, um dort arkadisch zu leben und im Schatten der Holunderb\u00fcsche Trautmanns und anderer bayerischer Schriftsteller beliebteste Werke zu lesen. Ein kleines Arkadien, in dem man mit der \nleichten Muse im Schatten der B\u00fcsche liegt \u2013 damit \n\u00e4hnelt die klassischen Sommerfrische den grossen Ferien in der Polaroid-Erinnerung.\nKlar, jetzt muss noch der Einwand behandelt wer -\nden. Vier Wochen am St\u00fcck weg, un-m\u00f6-glich! Aber k\u00e4me es nicht wenigstens auf einen Versuch an, in \neiner Zeit, in der unsere Arbeitsstrukturen ohnehin \naufweichen und die Technik die Gartenlaube oder die Terrasse auf Mykonos notfalls kurzfristig zu einem Schreibtisch machen k\u00f6nnen? W\u00e4re nicht jetzt genau die Zeit, eine Renaissance der Sommer -\nfrische einzul\u00e4uten, wo die Chefs doch mit Eltern-\nzeit, Teilzeitmodellen und dem Wunsch nach Work-\nLife-Balance Erfahrung gesammelt haben? W\u00e4re es \nnicht ein Experiment wert, sich mal zwei Drittel Jah-resurlaub zu sparen und gleichzeitig den Hass auf \ndie Arbeit zu mildern, den Stress an den Wochenen-\nden auszuschlafen, das Fernweh zur Not mit kurzen \nSt\u00e4dtereisen zu bes\u00e4nftigen und daf\u00fcr etwas Gro\u00dfes \nzu bekommen: einen ganzen Sommer. Den Flieder auf- und verbl\u00fchen sehen. Noch besser: Das ganzedahinstampfende Land mal einen Monat runterfah-\nren, und jeder besucht den Ort aus seinem Sommer -\nferien-Polaroid! Das ist nicht die k\u00fcnstliche Insel vor \nDubai, das ist viel g\u00fcnstiger. M\u00fcnchen, Frankfurt, Berlin \u2013 Gone Fishing! Keine schlimme letzte Ar -\nbeitswoche, weil ja alle wegfahren oder es zumin-dest voneinander annehmen. Wir k\u00e4men vielleicht \nnicht so knusprig braun zur\u00fcck wie die Herrschaften \nauf dem Solarium-Plakat, aber hallo, wir h\u00e4tten end-lich mal das Urlaubsgef\u00fchl nicht vorget\u00e4uscht.\nVon Max Scharnigg \n(S\u00fcddeutsche Zeitung am Wochenende, 09.08.2014)\nAnmerkung der Redaktion: Es gibt Texte, die vergisst \nman nicht. Dieser ist so sch\u00f6n, dass wir uns erlaubt haben,  ihn nach der Erstver\u00f6ffentlichung in der SZ \nnun auch in den DBM Facts zu publizieren. A \u201crefreshing\u201d experience\n\u201cStracciatella und Pistacchio im Cornet\u2026 bitte \nsch\u00f6n\u2026 das macht 4 Franken\u201d \u2013 I live new emotions \nand find myself in a different dimension when, on a \nSaturday or Sunday afternoon, I help my wife Gabri-\nella to sell the ice cream she produces (see https://\nwww.facebook.com/gabriellagelatoartigianale). \nHaving a business in the field of Italian gastronomy \nhas always been a dream for Gabriella, but I had al-\nways found good reasons to wait for more suitable \ntimes.  Now that the children are grown up, that \nwe could afford the necessary investment, that we \ncould use the parterre apartment of our renovated \nfarmer house, I could not find reasonable excuses: \nin mid-April we inaugurated an authentic Italian ice \ncream shop (\u201cgelateria\u201d)! Well\u2026 authentic is techni-\ncally only partially correct: Gabriella does use Ital-\nian ingredients of the highest quality (e.g., sicilian \nPistachios from Bronte, hazelnuts from Piemonte, \nlemon peel of fruits grown in my family garden on \nthe ligurian coast). However, she is proud of com-\nbining them with regional dairy products (e.g., swiss Biofarm organic milk and yogurt from the Bruder -\nholzhof in Oberwil, cream from the Manser Molki) or \u2013 upon availability \u2013 with locally picked fruits (e.g., \nfresh berries or cherries). The result therefore has \nto be acknowledged as a swiss-italian combination. \nBy the way, synthetic emulgators, flavors, colourings \nand preservatives are banned from her recipes, so \nthat her product complies with the strict definition of \nhomemade, artisanal ice cream (\u201cgelato artigianale\u201d).\nDuring the weekend, I truly enjoy standing behind \nthe ice cream window for a few hours to serve the \nvery diverse persons passing by the shop. The most \ndifficult but most adorable customers are the chil-\ndren: their smile when \u2013 after several changes of \nmind on the taste selection \u2013 I give them the filled \ncup or cone is a unique source of gratification! The \nteenager coming with the girlfriend and offering her \nan ice cream softens me up, in the memory of similar \nmoments I have lived a few years back\u2026 It\u2019s also not \ninfrequent to meet managers working in the pharma \nindustry and colleagues from the DBM or other re-\nsearch institutes, casually dressed after a hike or bike ride with their friends or family. Last week I even \nmet an artist who traded a charcoal drawing against \nsome vanilla ice cream.  I had initially expressed con-Entering the ice cream business\ncerns to Gabriella about my garden being \u2018invaded\u2019 by strangers, but now I find it fascinating to see it \nas a meeting point or stop-over, where people feel \nwelcomed and breath air of relax and friendliness. \nMy dream? That one day I can offer an ice cream to \nRoger Federer: ultimately, he is from Oberwil and \nmaybe he will decide to pass by\u2026\nThe most rewarding aspect of this \u201crefreshing\u201d expe-\nrience, however, is to see the enthusiasm, motiva-\ntion and gratification of Gabriella. She is finally ac-\ncomplishing what she had dreamt of and I am a living \nwitness of the truth in the motto \u201cHappy wife, happy \nlife\u201d! The children? They observe with curiosity and \ngive us some tips on how to make things attractive \nfor the market segment they represent, namely pro-\ngymnasium students. So far, with the excuse that they \nhave a lot of homework, they remain rather distant \nfrom the refrigerated window\u2026 unless they come to \ngrab an ice cream as an afternoon snack.\nAs marketing is the soul of business, I have to con-\nclude with an offer: gratis ice cream (medium size) to \nall of you who come to the shop with the personal copy of the DBMFacts. Don\u2019t worry, Radek\u2026 I\u2019m \nnot wasting the time of the DBM students\u2026 we\u2019ll \nsure have interesting scientific discussions there!\nIvan Martin\n42 SEASON  DEPARTEMENT BIOMEDIZIN\nDBM Facts 2|2015  Departement BiomedizinDBM Facts 2|2015  Department of BiomedicineDEPARTMENT BIOMEDICINE  DAS DBM STELLT SICH VOR  43\nHere I am writing a short contribu -\ntion to DBM Facts and wondering \nhow I got here? This is not what was supposed to happen, but, I guess like for many others, life continuously surprises with unex -\npected turns and events... But let\u2019s not jump ahead and start from the beginning:\nGrowing up at one of the many \nlakes in Switzerland and playing in \na wonderful backyard, I apparently developed an early curiosity for \u201cwhat is in there...\u201d for many things including those very bright and shiny flowers. In retrospect this almost seems like the beginning of a path to studying biology. But, not so fast. I was also fascinated by all things mechanical and went on to complete training as a \u201cMaschinenmechaniker\u201d.Today: Stefan Wieland,\nHepatology\nI really enjoyed handling the metal \nand building machines from the ground up. Not surprisingly, I was very much fascinated by the won -\nders of big machines especially the moon rocket Saturn V. Our neigh -\nbors (we had no TV) had to get up at 3 am in the morning so I could watch the moon landing of the Apollo 11 mission. But, with the big things came also the start of the era \nof miniaturization of such items as \nelectronic circuits, including mi -\ncroprocessors. This was exciting too and as a member of a \u201ccompu -\nter club\u201d we embarked on building our very own computer and used it for such mundane tasks as control -\nling an elevator or running an intri -\ncate model train system.\nAnd when did I become a biologist \nyou ask? Well, through all those times, a love for anything nature related was always with me. Hence, I very much enjoyed road trips that included simultaneous tinkering with my car and taking in the beau -\nties of, for example, the isle of Corsica. Professionally I eventually moved away from machines and \ncomputers, went back to school to \nacquire a \u201cMatura\u201d and then stud -\nied biology at the University of Zu -\nrich. As a \u201cWerkstudent\u201d I took on many different jobs including one that I presume has become com -\npletely obsolete in the internet era: at the time a few of us were sell -\ning the first batch of newly printed news papers shortly before mid -\nnight in the streets of Zurich under the heading \u201cTomorrow\u2019s News Paper\u201d. More importantly though, through one of my jobs I also got to know a \u201cChemielaborantin\u201d and we \nDBM Facts 2|2015  Departement Biomedizin44 DAS DBM STELLT SICH VOR  DEPARTEMENT BIOMEDIZIN\nbecame and remained each other\u2019s \nlife companions ever since.\nI finished my studies in the rela -\ntively young discipline of molecu -\nlar biology working on eukaryotic \npromoters, enhancers, transcrip -tion factors and their interplay that were the hot topics of the day. Un -\nexpectedly however, I took a turn again and started working with hepatitis B virus first in Zurich, then in Freiburg im Breisgau and then for a two-year postdoc experience \nin Southern California. But, oops, my wife and I stayed in San Diego for almost 20 years enjoying life at and outside of work. We grew especially fond of the desert scen -\nery and its special vegetation such as the Ocotillo (that doesn\u2019t really need support from my wife).\nThrough a story too long for this \narticle, and lasting friendships, I \nwas then given the exciting oppor -\ntunity to bring my hepatitis virus \nknowledge to the DBM and hope -\nfully contribute to the success of the lab and department while my wife acts as a pastor in a beautiful village im Baselbiet. Wait, wasn\u2019t she a Chemielaborantin? Well, she too remains continuously sur -\nprised by the unexpected turns and events life presents us with...DBM Facts 2|2015  Departement Biomedizin\u2026 nimmt uns Lukas Jeker mit in\ndie Forschungswelt der Molecular \nImmune Regulation \u2026arbeiten wir uns mit Stefan Herms durch riesige Mengen genetischer \nDaten\n\u2026stellt uns Mari Nakamura ihreHeimat Japan vor\n\u2026treffen wir mit Friederike Schulze Menschen, die noch B\u00fccher lesen\u2026lernen wir mit Ilija Lujic und Marc Bichsel, was Ausdauer ist\nNehmt hin mit Weinen oder Lachen\nNehmt hin mit Weinen oder Lachen,\nwas euch das Schicksal g\u00f6nnt:Kein K\u00f6nig kann euch gl\u00fccklich machen,wenn ihr es selbst nicht k\u00f6nnt.\n(Friedrich von Bodenstedt, 1819-1892)", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}